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Cell line models are of considerable value in anticancer research in terms of defining the
biological features of normal and transformed cells, and allowing genetic manipulation in
vitro. Recent evidence has shown that phenotypic reversion of transformed lines to a non-
transformed phenotype can be effected in vitro, for example via overexpression of the
guanine nucleotide exchange factor, Tiaml. A scientific understanding of these reversion
pathways may eventually provide targets amenable to therapeutic manipulation.
The KIM2 mammary cell line, containing a temperature-sensitive SV40 large T antigen,
was used as a model for normal and transformed mammary epithelial cells. At 37°C the
cell line appears epithelial and showed mammary differentiation (NKIM2), whereas at
33°C the cell line appears spindle-shaped and transformed (TKIM2). The aims of this
study were i) to determine the biological features of the NKJM2 and TKIM2 lines,
ii) revert the TKIM2 to a non-transformed phenotype by retrovirally transducing Tiaml
into the cell lines and iii) assess the reverted cells in terms of the originally defined
biological features.
TheNKIM2 cell line showed features of epithelial differentiation including cobblestone
morphology, E-cadherin and ZO-1 expression, junctions and polarisation. In addition, a
specialised myoepithelial cell type was identified among cultured cells. The NK1M2 cells
also showed mammary differentiation in terms of milk protein expression in response to
lactogenic hormones. In contrast, the TKIM2 line demonstrated accepted features of
transformation including spindle-shaped morphology, lack of contact inhibition and
serum dependence, anchorage-independence in soft agar and tumour formation in scid
mice. Although unexpectedly, the NKIM2 lines also formed tumours in scid mice. There
was no difference in the chromosomal locus for p53 and SEN6, which have been
implicated in transformation and immortalisation respectively, in both cell lines.
Retroviral transduction of control and active Tiaml constructs into both NKIM2 and
TKIM2 lines was successful, with Tiaml protein expression for three months following
transduction. This was associated with a reversion ofTKIM2 cells to an epithelioid
phenotype with E-cadherin expression and junction formation, although cells were not
polarised and some showed membrane ruffling. The reverted cells also demonstrated
milk protein expression, contact inhibition and serum dependence, but retained
anchorage-independent growth in soft agar.
In conclusion, both NKIM2 and TKIM2 mammary epithelial cells show features of
normal and transformed cell lines respectively. Introduction of Tiaml into cell lines
results in a partial reversion of transformed TKIM2 cells to an epithelial phenotype.
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Introduction
Breast cancer is the commonest cancer affecting females living in the developed world
[1]. The age-standardized incidence rates in the U.K., North America, Australasia, and
Scandinavia indicate that 60 to 70 per 100,000 women per annum will present with the
disease [2], Although the incidence rates of the disease are rising, in part due to
screening [3] and longer life expectancies [4], mortality rates appear unchanged [5], The
cause of most breast cancer remains unknown, but hormonal, environmental and genetic
factors are involved in its aetiology.
A significant feature of breast cancer is that although tumours appear slow-growing, by
the time they present clinically metastasis to distant sites may have already occurred [6,
7]. Thus, the overall 5-year survival rate for invasive breast carcinoma is 60% for
clinically localised disease, whereas for metastatic disease is 34% [1,8]. The current
strategies employed to tackle the disease include early mammographic detection by
screening and a combination of surgery, systemic hormonal and chemotherapy for
clinically established disease [9],
This study undertakes to understand at a cellular and molecular biological level certain
processes involved in breast carcinogenesis, by studying a cell culture model for breast
cancer and then manipulating it to 'cure' the disease in laboratory conditions [10].
In order to set a background to the experimental approach, breast cancer aetiology and
the relevance of in vitro breast cancer models will be discussed. In particular SV40 virus,
which is the immortalising agent of the KIM2 murine mammary epithelial cell line, will
be considered in detail. The introduction then assesses the relevance of the biological
markers which are used to characterise the normal and transformed KIM2 lines in this
study. This is followed by an overview of methods of gene transfer, with particular
reference to the retroviral approach undertaken. Finally, the phenomenon of phenotypic
reversion is considered and in particular current understanding of Tiaml, which is
transduced into KIM2 cells in this study.
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Aetiology
It is clear that although several risk factors for breast cancer have been identified, the
reason for a particular individual developing the disease remains unknown.
Hormonal factors
The female hormonal milieu appears to be associated with an increased risk of female
breast cancer [11]. This view developed from original observations about the difference
in frequency between male and female breast cancer. Male breast cancer is very rare,
accounting for less than 0.1 per cent of cancer deaths in men and occurring 100 times less
often than in women [12]. From meta-analysis, it is clear that gonadal ablation
significantly reduces the risk of female breast cancer, while actually increases the risk of
male breast cancer [13, 14].
Further epidemiological studies tend to support the view that female sex hormones play a
role in breast cancer, although the mechanism for this increased risk remains
controversial [15], Certainly an early menarche, which is reported to be associated with a
raised oestradiol level into early life, confers an increase risk of breast cancer [16], Early
menarche is likely to be triggered by a threshold level of adipose tissue, which is reached
sooner in Western societies [17], The raised and prolonged exposure to oestrogens such
as oestradiol, is described as the 'oestrogenic period' [16]. How pregnancy effects this
period remains contraversial. It is reported that pregnancy at an early age, decreases
breast cancer risk [18]. One possible explanation is that the breast contains contains stem
cells which are at neoplastic risk before they have been stimulated to differentiate during
pregnancy [19]. Previously it has been suggested that ifwomen actually become
pregnant after a diagnosis of breast cancer, they have poorer survival rates than their non¬
pregnant counterpart. However the most recent evidence shows that there is no difference
in mortality between the two groups [20], If the 'oestrogenic period' is prolonged either
by delayed menopause or exogenous oestrogen such as Hormone Replacement Therapy
(H.R.T.) or the oral contraceptive pill, there is reported to be increased cancer risk [16],
Certainly, studies linking exogenous oestrogen to breast cancer have raised public
concern. The evidence concerning the pill remains unclear [21]. Certain studies have
suggested an increased risk in women below the age of 35, the risk increasing the longer
the pill is used and with preparations containing high levels of oestrogen [22],
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However any possible risk with the use of the newer combined pill, which contains lower dose
oestrogen and progesterone, is thought to be small [23], The most recent meta-analysis studies
on H. R. T. suggest that there is a small but significant increase in cancer risk with long-term use
[24]. At present, patients who have had previous breast cancer and those at increased risk, are
advised to be offered H.R.T. only with caution and full information of risks, while the need for
results from a large, longitudinal, randomized control trial remain [25, 26],
Perhaps the most significant recent evidence in relation to the influence of hormones on breast
cancer have been treatment based [27]. In the 1950's the use of anti-oestrogens was explored in
order to control advanced breast cancer. This was particularly of interest because the existing
alternatives: oophorectomy and adrenalectomy had undesirable side-effects [28], The current
most widely used anti-oestrogen tamoxifen, has been shown to induce regression of tumour in a
significant proportion of advanced breast cancers [29],Further to this, it has been shown by
meta-analysis that post-surgical adjuvant tamoxifen therapy actually improves survival [30]. An
alternative strategy includes use of long-acting LHRH agonists such as Zoladex which
eventually suppress gonadotrophin release and block gonadal fiinction.However the most recent
anti-oestrogen therapies under trial are the aromatase inhibitors, which reduce the conversion of
androgens to oestrogen [33].
Environmental factors
There is a striking variability in the geographic distribution of female breast cancer [2], In
contrast with the age-standardised incidence rate quoted earlier of 60-70 cases per hundred
thousand per annum for some Western countries, the rate in Asian countries may be only 15
cases per hundred thousand [34]. This difference in risk appears to have a strong environmental
component because those who migrate from a low risk area to high risk area, increase their risk
[35, 36], This increased risk is also continued in their descendants. To identify the principles
involved in environmental factors is notoriously difficult. There is a reported increased risk of
breast cancer in urban rather than rural areas, with certain groups in Western countries, such as
Mormons, having a decreased risk [37], Another often quoted example, is the large excess of
dietary fat consumed in Western countries compared to some Asian countries [38].
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The mechanistic theories put forward are controversial [39]. It is possible that increased
dietary fat triggers early menarche, as previously mentioned, and therefore increases
breast cancer risk indirectly, by prolonging exposure to oestrogen. It may also be that
increased fat affects oetrogen metabolism and therefore increases circulating levels of
oestradiol [40]. It has also been proposed that the fatty acid profile of the Western diet as
well genetic influences, predisposes to earlier hyperinsulinaemia [41],
Hyperinsulinaemia, which may result in insulin resistance at puberty, is associated with
abnormal aromatase activity in the ovaries, as well as increased levels of insulin-like
growth factor (IGF) [17]. It is thought that abnormal aromatase activity resulting in
increased oestrogen levels, synergises with IGF to stimulate proliferative activity in
mammary epithelium [17]. These theories have translated into attempts to modify diet
and exercise in families at increased risk of breast cancer. Indeed certain studies suggest
that a very low fat intake reduces breast cancer risk [42],
The studies on obesity, which intuitively would follow diet, differ slightly. Most studies
show obesity in Western women is associated with increased cancer risk in
postmenopausal women [17], However, obesity in teenage girls, actually appears to
reduce the cancer risk in premenopausal women [41]. The explanation for this particular
decreased risk is unclear. However after the menopause, adipose tissue becomes the
major site of aromatase activity and source of oestrogen, so that the protective effect of
early obesity is replaced by an increased risk of postmenopausal cancer if obesity persists
beyond teenage years [41].
Genetic factors
While most cases of breast cancer are sporadic and not familial, genetics appears to play
a role in certain scenarios. For example, if one or more first or second degree relatives
have breast cancer, the increased risk to an individual can be two to five times the
average risk [43]. Further to this, the identification of two inherited breast cancer
susceptibility genes namely BRCA1 [44] and BRCA2 [45], by world wide analysis of
approximately 200 breast cancer prone families, underlined the importance genetic
disposition in breast cancer.
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Although the mechanism by which mutations in these genes prediposes to cancer is not
yet full understood, these discoveries may help to identify biology peculiar to breast
cancer. BRCA1 has been shown in studies of the prevalence and penetrance of germline
mutations, to be present in populations unselected for a family history of breast cancer
[46], For example, 13% of women diagnosed with breast cancer under 30 and 7%
diagnosed under the age of 35 have germline BRCA1 mutations, although the
significance of these mutations is unclear [47, 48]. Somatic mutations ofBRCA1 are seen
very infrequently in sporadic breast cancer [46]. The function of BRCA1 is difficult to
elucidate from its primary structure with the only clue being a conserved RING finger
domain, which is a type of zinc finger domain whose function is not well understood
[46].
Studies show that mouse BRCA1 shares only 58% amino acid homology with human
BRCA1, therefore weakening the power of experimental studies in mice [49], Mouse
homozygous BRCA1 knockouts die in utero with multiple developmental abnormalities,
however the heterozygotes have shown no evidence of tumour development at 6 months
[50]. The most recent study using the Cre-Lox system to conditionally express a mutation
of BRCA1 in the mammary gland, resulted in blunted ductal morphogenesis and tumour
formation [51].
The development of antibodies to the BRCA1 protein has yielded opposing observations
regarding the cellular location of BRCA1. One proposal has been that BRCA1 is not
present and therefore excluded from the nucleus of breast cancer cells, and so is unable to
function [52], However others have detected BRCA1 in the nucleus of both normal and
cancer cells associated with membranes and propose that BRCA1 is a granin protein,
whose secretion by definition is regulated by signals from the extracellular environment
[53], This theory remains contraversial.
There have been attempts to demonstrate the functional biology of BRCA1 in sporadic
breast cancer cell lines. The introduction of a normal BRCA1 cDNA expression
construct, results in a reduction in proliferation and tumour forming ability of the cell
lines [54], Unfortunately these cell lines already contain a normal BRCA1 copy, so it is
unclear whether the construct raises BRCA1 levels (mRNA or protein) to 'normal' levels
present in the original cancer progenitor cell, or highly overexpresses BRCA1.
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Interestingly when mutated BRCA1 constructs are introduced, they lose the ability to suppress
the tumour forming ability of these breast cancer cell lines, although they retain the ability to
suppress ovarian cancer cell lines. It is tempting to draw parallels with particular human
mutations of the BRCA1 protein which are high risk for breast cancer, but low for ovarian
cancer [55],
BRCA2 germline mutations were identified as a common factor in a proportion of the remaining
cancer prone families, with their risk of breast cancer estimated at 70% by age 70 [45].
Interestingly the male breast cancer risk conferred by BRCA2 is 200 fold that of the general
population [56]. Evidence regarding BRCA2 is still unfolding. Structurally, BRCA2 also
contains a granin motif as well as homology with a predicted protein in C. Elegans, but the
functional significance of both observations is still unclear [57].
The most recent evidence has implicated both BRCA1 and BRCA2 in DNA repair. It is clear
that both BRCA1 and BRCA2 can bind the transactivation domain of Rad51 [57a]. Rad51 is
known to be involved in DNA recombination and repair. This is further supported by the
induction of phosphorylation of BRCA1 in response to DNA damage. It is likely that BRCA1
and 2 function as transcription factors to DNA repair genes. As well as Rad51, BRCA1 can bind
several specific trancriptional regulators like p53, myc, CtlP and E2F.Recent experiments with
knockout mice support the role of BRCA1 and BRCA2 protens in DNA recombination and
repair of double-strand DNA breaks [57a],
The tumour suppressor gene p53 may also play a role in inherited genetics predisposing
to breast cancer. In studies of patients with Li Fraumeni's syndrome, who have germline
mutations in p53, the majority of these patients develop cancers by early middle age [58]. Of
these, breast cancer appears to be one of the most frequently developed cancers. Other
mutations which confer an inherited risk for breast cancer include rare mutant alleles of the
androgen receptor [59] and mutations present in ataxia-telangiectasia [60], Current studies are
underway to study the disease implications of the Cowden disease gene PTEN/MMAC1 [61].
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Gene effects in breast cancer
In discussion of genes involved in cancer in general a dichotomy has been
recognised. Some genes are altered in expression by mutation, others by changes
in their regulation (see below).
In contrast to human breast carcinogenesis spontaneous tumours in mice have a
viral aetiology such as the mouse mammary tumour virus (MMTV) [98], while in
humans, tumour aetiology remains largely unknown. Human MMTV-like
elements known as human endogenous retroviral elements (HERVs) have been
observed in breast cancer [99], but their biological significance remains
unknown. This discussion will compare the gene effects in spontaneous human
and mouse breast cancer. A detailed discussion of the relevance ofmouse models







No alteration at the DNA level
Genes affecting phenotype by
expression changes
Class I
In studies of human breast cancers the common oncogenes affected appear to be
c myc, c-erbB-2 (neu/HER2) and PRAD-l/cyclinDl [65]. Of particular interest is
c-erbB-2, which encodes a transmembrane protein with tyrosine kinase activity
[66], Amplification of c-erbB-2 is seen in almost all cases of an in situ cancer
known as comedo intraductal carcinoma, as well as 10% to 40% of invasive
ductal carcinomas [67, 68], Certain studies have shown that amplification and
overexpression of c-erb B-2 correlates with decreased survival from breast cancer
[69], However in multivariate analysis, this feature is overshadowed by
morphological parameters, specifically tumour grade [70], It is also suggested
that patients that overexpress c-erbB-2 show a reduced response to adjuvant
chemotherapy and hormonal treatment [70], In contrast, in studies ofmurine
cancers MMTV activates putative proto-oncogenes which appear to be important
in mouse carcinogenesis. These include two members of the Wnt gene family
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(Wnt-1 and Wnt-3), three members of the fibroblast growth factor (Fgf) gene
family, and int-3, a mammalian Notch gene, for which in vivo human
counterparts have not yet been identified [100],
In mouse mammary epithelial cells, MMTV integration activates Wnt-1 by
increasing transcription ofWnt-1 mRNA leading to increased (tumourigenic)
levels of the normal Wnt-1 protein.While the normal function ofWnt- family is
not completely elucidated, Wnt expression is maximal during periods of
morphological change and is lost during the terminal differentiation that
accompanies lactation. The best current model to explain Wnt induced neoplasia
is the theory that Wnt-1 and Wnt-3 functionally substitute for one or more
endogenous Wnt genes and drive inappropriate cellular proliferation [337], It has
been shown that members of the FGF family co-operate with MMTV-Wnt-1 in
the generation ofmouse mammary tumours [338], Data on the role of int-3 in
mammary carcinogenesis is limited.
Human breast cancers are prone to mutations in tumour suppressor genes [65],
whereas this is not a prominent feature in mouse mammary tumour formation.
p53, the tumour suppressor mutated in the majority of human cancers, is mutated
or deleted in approximately 20-40% of sporadic breast cancer [71]. It has been
shown that p53 mutations are present in carcinoma-in situ lesions which are at
increased risk of progressing to cancer, but not in simple hyperproliferative
lesions. In mouse transgenic models, the loss of p53 is not sufficient to cause
mammary tumours alone, but it appears to cooperate with a second oncogene,
such as Wnt 1 to greatly increase the rate ofmammary carcinogenesis [72, 73].
While loss of p53 is not a key feature in spontaneous MMTV tumourigenesis it
has been described in relation to hyperplastic alveolar nodules (HAN). These
lesions are a loosely equivalent group of preneoplastic lesions to human DCIS
identified by De Ome et al [101]. If HAN lines are perpetuated by serial
transplantation into cleared mammary fat pads of syngeneic virgin mice, a
proportion form tumours [95, 102, 102]. HAN have been further subdivided
according to their degree of immortalisation, degree of hyperplasia and tumour-
forming potential. There appears to be progression between these stages of HAN
in the mouse, which is associated with the loss of functional p53 and alteration in
cyclin function [105].
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The retinoblastoma (Rb ) tumour suppressor gene appears to undergo germline
mutations in some human breast cancers to a lesser extent than p53, while
somatic mutations have been reported in certain cases [74]. Loss of
heterozygosity in human breast cancers, which may point to loss of other tumour
suppressor genes has also been detected on chromosomes lp, lq, 3p, lip, 13q,
17p, and 18q [65],
Class II
The Class II genes include those involved in invasion and metastasis and have
been extensively evaluated in human carcinogenesis. Data on these genes in mice
is derived from mouse models
rather than spontaneous tumours. These 'metastogenes' are key players in
physiological processes such as inflammation, embryogenesis, placentation,
organogenesis, lymphocyte activation and stem cell differentiation [328].




Survival Tumour endothelial- cell interaction Metastasis
(Angiogenesis)
Tumour microenvironment interaction
In both human and mouse, tumour-stroma reactions result in localized proteolysis
mediating tumour invasion and metastasis. A number of well-described genes
which are clinically relevant include those controlling extracellular matrix,
plasminogenolytic and angiogenesis pathways. Components of the
plasminogenolytic systems such as uPA, uPAR, PA1-1 and Matrix
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Metalloproteinases (MMP's) are expressed in a complementary fashion [329],
Angiogenesis is brought about by a paracrine interplay between tumour cells and
endothelial cells. In particular Vascular endothelial growth factor (VEGF) is
synthesised by tumour cells, whereas its receptors VEGFR-1,2 and 3 are
expressed by proliferation endothelial cells[330].
Genes with evidence for involvement in breast cancer invasion and metastasis ,
which may become more clinically relevant include S100A4, mta-1 (metastasis
associated gene-1), and MUC 1 [331],
S100A4 is upregulated in rodent metastatic mammary carcinoma models.
Moreover S100A4 promotes invasion in human breast cancer lines and has been
identified in association with distant metastasis in breast cancer surgical
specimens [333]. It is hypothesised that S100A4 regulates cytoskeletal dynamics
ofmetastatic cells through modulation of myosin phosphorylation. Similarly,
Mta-1 was isolated in a rat mammary adenocarcinoma model system, with an
increase in metastatic phenotype [334],and expression of mta-1 is correlated
with metastatic capacity in two human model systems. Mta-1 seems to be a
component of intracellular signalling pathways since it contains domains which
are involved in protein-protein interactions and associated with cytoskeletal
components. Inhibition ofmta-1 by an antisense nucleotide results in inhibition
of human and mouse breast cancer cell line motility and proliferation. An
additional Class II 'metastogene' is MUC-1, a heavily glycosylated type 1
transmembrane protein [335]. An underglycosylated form ofMUC-1 is expressed
in invasive human breast tumours. Data from mouse models is awaited.The
effects ofMUC 1 include inhibition of cell-cell and cell-matrix interactions,
immunosuppressive effects and induction of apoptosis in activated T cells.
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Models ofmammary gland
Before discussing mammary models, it is relevant to assess the similarities between
normal structure and physiology of human and mouse mammary gland, in order to
determine the relevance ofmodels to human disease. In both the mammary gland is a
secretory organ, composed of glandular tissue and ducts contained in a stroma of
supporting fat and fibrous tissue [75]. The primary function is to manufacture and deliver
milk during lactation, under the control of steroid hormones, peptide hormones and
growth factors.There are similarities between human and mouse in terms of
corresponding stages ofmammary development. The development of human and mouse
mammary glands is promoted by puberty or the onset of ovarian cycling [75], However,
functional maturity with differentiation of luminal epithelial cells for milk production,
only occurs during pregnancy. After weaning in the mouse, the gland is remodelled and
has the appearance of that of a mature virgin within a few weeks [76], In humans,
mammary involution takes approximately three months and there is a return to a more
ductular system, as seen before pregnancy.
Structurally the glandular units in both human and mouse are lobules with sac-like ends
known as alveoli. A coalescing system of ducts drains the lobules, eventually emerging
on to the surface at the nipple [77]. The lobules are lined by an inner layer of luminal
epithelial cells and a second outer layer ofmyoepithelial cells. The characteristic
cuboidal epithelial cells are able to secrete milk proteins, and it is from this layer that the
majority of breast cancers arise [78]. In both human and mouse the outer layer of
myoepithelial cells have specialised contractile actin elements, which are thought to
contract to help express milk during suckling [79, 80]. These structural and physiological
similarities have lead to a number ofmouse models being used experimentally [81],
However perhaps the main advantage of the mouse is that its genome is extensively
mapped.
In order to model the normal mammary gland in vitro a number of approaches have
evolved. Whole organ or explant cultures can be employed [82]; however their main
disadvantage is the inability to distinguish the effects of epithelial cells from stromal
components. In order to examine epithelial-stromal interactions in a more controlled
environment, a coculture system, in which a monolayer of stromal adipocytes or
fibroblasts are seeded with mammary epithelial cells has been developed [83],
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This system is complicated experimentally by the differing serum requirements of
stromal cells and epithelial cells. However, with improved separation techniques it is
possible to develop mammary epithelial cell primary cultures which are fibroblast- free
[84], The particular difficulty of primary cell culture ie growing cells directly from
tissue, is that the cells have a limited number of doublings before they senesce or enter
crisis [85], It has been observed however that very rare cell lines could overcome crisis
and be cultured indefinitely. These spontaneously immortalized mammary epithelial lines
originally derived from mid-pregnant Balb-c mice were termed the COMMA-ID line
[86], This parental line gave rise to the CID9 [87] and HC11 lines [88]. The model line
for 'normal breast' quoted extensively in the literature is the HC11 cell line [88]. These
spontaneously immortalized cells, differentiate in the presence of lactogenic hormones to
produce early diffentiation markers such as the milk protein beta casein (P-casein).
However, they have a limited ability to express late differentiation markers such as Whey
Acidic Protein (WAP) and alpha lactalbumin. The increased lifespan ofHC11 cells is
attributed to the lack of wild type p53, but whether this leads to alteration of the
differentiation pathways being examined in the cells, remains unclear [89].
The random derivation of spontaneously immortalized cell lines remains a disadvantage.
Genetic manipulation can therefore 'immortalize' cells in a controlled manner. The most
effective strategies appear to be introduction of the nuclear oncogene myc, the GTP
binding protein Ras or DNA tumour virus immortalizing genes [90], A notable example
of the effect ofDNA virus is work by Jat et al, who developed the transgenic
immortomouse, which carries a temperature-sensitive Simian Virus 40 (SV40) large T
antigen under the control of a housekeeping gene promoter H-2Kb [91], This promoter
directs expression to a wide range of tissues and can be induced in vitro using gamma
interferon. At low levels, SV40 large T antigen allows the immortalization of various cell
lines including thymocytes, colon crypt and bone precursors [91, 92], Unfortunately
mammary epithelial cell lines have not been derived from the original immortomouse
because there was insufficient expression of the transgene large T antigen in the
mammary secretory epithelium.
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Mammary epithelium may be targetted specifically by using milk protein gene promoters
such as beta casein, whey acidic protein and lactoglobulin or the mammary mouse
tumour virus promoter (MMTV) [93], This approach has been used successfully to
introduce a temperature-sensitive SV40 large T antigen in the KIM 2 mammary epithelial
cell line, which is targeted via the beta lactoglobulin promoter [94]
An alternative in vivo model to transgenic mice and cell lines, is to use cleared fat pads
[95]. This involves the genetic manipulation ofmammary epithelial cells in culture
before transplantation into the cleared fat pad of syngeneic mice. The epithelial cells then
regenerate to form a mammary tree which varies in phenotype according to the gene
introduced. A possible disadvantage is the immune response of the host to the cells
transplanted, but this can be overcome using immunodeficient animals [96] .The cleared
fat pad approach has been used successfully, particularly with reference to
tumourigenesis experiments [97],
Models of mammary carcinogenesis
Spontaneous tumours in mice tend to have a viral aetiology such as the mouse retrovirus-
(MMTV) [98], while in humans, tumour aetiology remains largely unknown. Human
MMTV-like elements known as human endogenous retroviral elements (HERVs) have
been observed in human breast cancers [99], but their biological significance is still
unclear. In the mouse the MMTV is passed from mother to offspring in milk and is
dependent on glucocorticoid expression for transmission, whereas no analagous agent is
identified in humans. MMTV activates putative proto-oncogenes which appear to be
important in mouse carcinogenesis. These include two members of the Wnt gene family
(Wnt-1 and Wnt-3), three members of the fibroblast growth factor (Fgf) gene family, and
int-3, a mammalian Notch gene, for which in vivo human counterparts have not yet been
identified [100].
While accepting that the aetiology of spontaneous tumours may differ, it is relevant to
assess the stages of development in mouse and human tumourigenesis. In the human,
preneoplastic lesions (atypical hyperplasias) have been identified which may be
associated with increased cancer risk. In the mouse a loosely equivalent group of
preneoplastic lesions (hyperplastic alveolar nodules (HAN)) have been identified by
DeOme et al [101].
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When transplanted into the cleared mammary fat pads of syngeneic virgin mice, HAN
grow and fill the fat pad with alveolar cells similar to the normal pregnant gland.
However, if these lines are perpetuated by serial transplantation into cleared fat pads, a
proportion form tumours [95, 102, 103]. HAN have been further subdivided according to
their immortalization, degree of hyperplasia and tumour- forming potential. In human
lesions a similar subdivision has been described into ductal hyperplasias, atypical
hyperplasia and carcinoma in situ [104], There appears to be progression between stages
ofHAN in the mouse, which is associated with loss of functional p53 and alteration in
cyclin function [105],
Apart from spontaneous models of tumourigenesis in the mouse, there are a number of
transgenic models to study breast cancer. The most common promoters used to target the
mammary epithelium include mouse mammary tumour virus (MMTV), whey acidic
protein (WAP) and beta lactoglobulin (BLG). In broad terms the transgenic models
currently studied are grouped into those with altered growth regulators, cell cycle
proteins, matrix proteinases, apoptosis proteins and viral oncoproteins [106], Although
some models are applicable to gene defects observed in human breast cancer, others are
more useful for studying mechanisms relevant to carcinogenesis in general. Moreover,
although such female transgenic animals may develop mammary tumours, many require
additional manipulations before cancers appear [107], The group of transgenic models




In 1960, SV40 virus was originally identified in rhesus monkey kidney cells, which were
also being used to prepare polio and adenovaccines [110]. The virus caused no
cytopathic effects in rhesus monkey kidney cells, but when the infected cells were
injected into newborn hamsters, sarcomas appeared at the subcutaneous site of
innoculation [111]. Hamsters also developed ependymomas when SV40 virus was
injected into the brain [111]. These experiments first pointed to SV40's oncogenic
potential and since then the debate over the effect of SV40 on humans has continued. It is
clear that SV40 virus had contaminated both the Salk and Sabin poliovaccines [112].
These contaminated vaccines were used in a number of experiments which are ethically
questionable today. For instance, it was observed that when human adults were injected
with the contaminated Salk polivaccine, they developed neutralizing antibodies against
SV40 [112]. Although there was no evidence of symptoms in these patients, it became
clear that the virus was replicating in humans. For example, children given the
contaminated SV40 oral Sabin vaccines excreted virus in the stools for approximately 5
weeks following administration [113].
Despite this, large scale epidemiological studies have not demonstrated a general
increased risk of tumour formation (including ependymomas and sarcomas) in the
populations receiving contaminated vaccines [115]. The only striking observation is an
increased incidence in mesotheliomas, but this would correspond to the relatively small
numbers of adults vaccinated with poliovaccines [115]. Other studies have identified
SV40 virus in tumours such as meningiomas, but contaminated vaccine-exposure was not
confirmed in these patients [117].
However, although no marked association with tumour incidence has been demonstrated,
the effects of SV40 in cell culture are striking and have underpinned numerous studies
of carcinogenesis. It was found that SV40 virus transformed a proportion of human cells
in culture [118]. They were termed semi-permissive because SV40 virus could both
replicate in human cells and transform them. Rodent cells are non-permissive because
they do not support SV40 replication, although they do transform. In contrast, monkey
cells are permissive because they support SV40 virus replication. Since then numerous
studies have shown that SV40 virus can alter normal cell growth in rodent cultures and in
its role has been examined in over 20 distinct cell types in transgenic mice [119],
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Mechanism of immortalization and transformation
SV40 is a small circular DNA virus (5432bp), whose immortalization and transforming
ability is attributed to two early gene products - small and large tumour T antigen [120].
Both small T and large Tantigen are transcribed from the same transcriptional unit but are
differentially spliced. The large T antigen binds to tumour suppressor genes p53 and pRb
which are normally involved in cell cycle regulation [121], It may be that abrogation of
these checks allows a cell in culture to divide in an uncontrolled manner, and that
accumulation of chromosomal damage predisposes to either immortalization or
transformation. Both p53 and pRb may be mutated in human cancers [122], Indeed
mutations of the tumour suppressor gene p53 are the most common genetic alterations
observed in human malignancies. p53 has been termed the 'guardian of the genome' due
to its ability to induce cell cycle arrest or apoptosis in reponse to DNA damage caused
by ionising radiation or cytotoxics [123], pRb was originally described in childhood
retinoblastoma and is mutated in far fewer human malignancies than p53 [128], It binds
to certain cell cycle regulatory proteins depending on its phosporylation status [129], In
GO when Rb is dephosphorylated, it inhibits the transcription of genes such as fos and
myc that are necessary for proliferation. Growth factors relieve the inhibition exerted by
Rb, by causing the protein to become phosphorylated on multiple serines and threonines.
In the virus lifecycle, large T antigen allows the virus to bypass these normal controls and
thereby replicate faster than the host cell [120]. Large T also binds other proteins such as
the pRb-related proteins pi07 and pi30, and inactivates them at its J domain [130], The J
domain has homology to the DNA J-family of molecular chaperone proteins, but the
functional significance of the interaction remains unclear [130]. The role of small T
antigen is still contraversial, although it is known to regulate protein phosphatase 2a and
is thought to aid the transformation of specific cell types, eg murine ductal epithelial cells
in liver and kidney [131].
In order to examine the function of large T antigen in mammary gland a number of
transgenic mice have been developed resulting in different phenotypes. Mice created
using a WAP-SV40 large T hybrid gene produced lines which developed mammary
carcinomata coinciding with lactation [93], or those who showed a high level of p53-
independent apoptosis during pregnancy followed by impaired milk protein production
[132].
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Whether large T antigen acting through p53 and pRb alone, causes cell immortalization
or transformation remains uncertain. Transgenic mice with a T antigen-MMTV promoter
in a tetracycline-responsive system, developed cellular transformation and salivary gland
hyperplasia by 4 months of age. IfT antigen was silenced at this stage, the hyperplasia
and cell changes regressed. However, ifT antigen was silenced at 7 months of age or
later, the hyperplasia and cell changes remained [133]. It has also been shown that cells
originally transformed with T antigen remain transformed even when negligible levels of
T antigen are present, and there is no evidence of binding to p53 or pRb. It has therefore
been proposed that chromosome rearrangements as a result of inadequate policing of the
cell cycle play a role in maintaining the transformed or immortalized state [115]. The
most recent evidence is from normal human fibroblasts in culture which, unlike rodents
cultures, rarely if ever spontaneously immortalize. Comparison between fibroblasts
which immortalize with SV40 virus and those which do not, has identified mutation of a
gene on chromosome 6 (6q26-27), designated SEN6, which is thought to be key for
immortalization [134-136]. Inactivation of SEN6 may be responsible for immortalization
of tumours including non-Hodgkins lymphoma, mammary carcinoma and ovarian
carcinoma which show loss of heterozygosity in 6q26-27 [134],
Why certain cells retain normal characteristics and simply divide indefinitely, whereas
others fulfill the criteria for transformation with T antigen remains unknown. It has been
proposed that low levels of T antigen are more likely to simply immortalize cells, whereas
high levels result in full transformation [120], T antigen remains the basis for
immortalization of a number of'normal' cell lines [120], In this respect a frequently used
technique is to use a temperature- sensitive mutant of T antigen. At a permissive
temperature thermolabile mutants have the same properties as wild-type T antigen,
whereas at the restrictive temperature T antigen is inactive. One of these mutants is tsA58
which has a cytosine changed to thymidine [91], resulting in the substitution of an alanine
residue for valine within an ATP ase binding domain. There is still controversy as to
whether at the restrictive temperature there is a conformational change in tsA58 which
renders it inactive [137] or whether mRNA is rapidly degraded [138].
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KIM2 cells are mammary epithelial cells developed using the the tsA58 targeted to the
mouse mammary gland using the ovine beta lactoglobulin promoter (BLG) [94],
At a semi-permissive temperature of 37 °C, when T antigen is active at low levels, KIM2
cells appear epithelial and are stable in phenotype for over 60 passages. However cells
derived at the permissive temperature of 33 °C -when T antigen is active at high levels,
appear spindle shaped and transformed. Very early passage cells appear to be able to
switch phenotypes according to temperature, whereas this ability is lost once cell lines are
established in culture [94].
In summary there are a number of hormonal, environmental, and genetic influences in
human breast carcinogenesis. Mouse mammary cell lines have certain benefits as well as
disadvantages as experimental models of this process. One example of a mechanism for
immortalizing and transforming cells is a temperature-sensitive SV40 virus large T
antigen, which provides a model for examining both normal and transformed mammary
epithelial cells in vitro.
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Aims of the study
The KIM2 mammary epithelial cell line immortalized by SV40 virus may be a useful cell
culture model of normal and transformed mammary epithelia. Genetic manipulation of this
model may result in the reversion of the transformed phenotype to a non-transformed
phenotype.
The aims of this study were therefore to:
i. examine the biological features of epithelial and mammary differentiation in
'normal' mammary KIM2 epithelial cells
ii. examine the features of transformation in 'transformed' KIM2 cells
iii. revert the 'transformed' cells to a normal phenotype by introducing Tiaml
constructs using retroviral methods
iv. confirm the extent of the reversion in terms of the biological reference points
established in i,ii
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Potential markers of differentiation and transformation
Much research in cell biology is devoted to determining the difference between normal
and cancer cells [139]. The difficulty with this approach is that many of the differences in
vitro, may not be relevant to malignancy. The so-called 'normal' cellular phenotype that
will be considered, is subject to the reservation that cell lines may have been
immortalized. The phenomenon of immortalization results in an indefinite lifespan in
culture, which will almost certainly effect numerous normal cell signalling pathways.
The 'transformed' cellular phenotype refers to tumour cells in culture in vitro, and is
thought to be analagous to 'tumourigenicity' in vivo.
Certain criteria have been put forward based on experimental observations, to define
normal and transformed cells [140], These criteria will be considered and their relevance
to normal and cancer cells discussed.
Morphology and contact inhibition
Cells in culture may change their morphology depending on their physical, biological and
biochemical environment [141]. For instance, scanning electron microscopic studies have
shown that cells radically change morphology during the cell cycle [141], Despite this, it
appears possible to distinguish between normal and transformed cells in culture using
morphological features, even though these differences may be as a result of artefact.
Moreover, morphological changes in culture are among the first alterations described,
when normal cells transform due to the action of specific viral genes [142, 143],
Classically, normal epithelial cells form a cobblestone, cuboidal shape in culture and
grow as a flattened monolayer. Interdigitation of the cytoplasm of certain epithelial cell
types has been observed under electron microscopy [144], Normal fibroblasts have an
elongated spindle-shaped appearance and they similarly grow as a flat monolayer with
interdigitation, although overlapping of cells is sometimes observed [144], Transformed
cells in culture are elongated and spindle-shaped similar to fibroblasts, but are
pleomorphic and more rounded in cross section on electron microscopy. The rounded
appearance is thought to be reflective of reduced adhesion to the substratum [145].
Transformed cells also show a lack of contact inhibition, which results in multilayering of
cells in an anarchic fashion. Contact inhibition ofmovement was first described in
normal cells, which, when they collide, turn aside and move away in different directions
[146],
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This lack of positional control in transformed cells, as opposed to lack of growth control,
may parallel the invasive properties of cancerous cells in vivo. For example, it is clear
that epithelial stem cells can proliferate in vivo, but the progeny tend not to cross the
boundary to penetrate tissue of a different type. However, cancerous epithelial cells move
outside their territory and in some cases, also cause breakdown of surrounding tissues
[147], From these observations it has been proposed that a number of the molecular
targets for transformation, are normally responsible for organisation of the cytoskeleton
and cell-cell contacts [148]. At an ultrastructural level, normal and transformed cells may
differ in terms of cell surface glycoproteins and cytoskeleton including actin filaments
and microtubules [149, 150], However exceptions include certain cell lines that are
transformed in terms of loss of growth control, and retain a normal cytoskeleton.
Furthermore, cells lose cytoskeletal structure during mitosis and when removed from a
solid substrate, but do not transform [151].
Epithelial junctions and polarity.
Given the lack of contact inhibition of transformed cells, it follows that they do not form
complete cell junctions. In simple terms, cell junctions have been classified into tight
junctions, communicating junctions and anchoring (adherens) junctions [152], Studies
have shown it is the anchoring junctions, mediated by the transmembrane protein E-
cadherin, which are characteristic of the sheets formed by epithelia [153]. Cadherins are
responsible for calcium-dependent homophilic binding in vertebrates, which links actin
cytoskeletons between cells [154], A highly conserved cytoplasmic domain of cadherins
interacts with the actin cortex by means of atleast three intracellular attachment protein
known as catenins [155]. At a molecular level, transformed epithelial cells in vivo and in
vitro lose these functional cadherin-catenin complexes which underpin the anchoring
junctions [148]. The presence of anchoring junctions termed adherens junctions,
desmosomes and hemidesmosones respectively, can be identified by electron microscopy
[152],
The tight junction is an alternative junction which may be detected in epithelia [156],
although these junctions undergo changes in junctional integrity in the pregnant
mammary gland in vivo [156], The specific immunohistochemical marker of these
junctions is the protein Zonula Occludens 1 (ZO-1), which lies on the cytoplasmic aspect
of the junction [156],
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Although E-cadherin and ZO-1 are useful markers of epithelial junctions, the
intermediate filament keratin, is an alternative marker that allows the identification and
classification of epithelial tumours which have lost junctional specialisiations [157, 158].
It is also used for tracing back the origin of metastatic carcinomas [159].
Cell polarity also remains the domain of the normal rather than transformed cell [160], It
is vital to mammary epithelial cells, which secrete milk proteins across the apical cell
membrane into the lumen of alveoli in vivo. In cell culture polarity can be assessed on
electron microscopy by the identification of apical microvilli which form a continuous
surface between cells [161]. An alternative method involves identifying Na K ATP ase
channels by immunohistochemistry which are present on the basolateral aspect of the cell
only [161].
Mammary differentiation
Mammary differentiation of cell lines is assessed in terms ofmilk protein secretion in
response to lactogenic hormones. However, the feature of milk protein secretion has been
described in both normal epithelial and certain transformed mammary cell lines in culture
[108]. The proteins can be secreted in response to lactogenic hormones such as prolactin,
insulin and dexamethasone [162]. The two groups of proteins which may be produced
include caseins, which precipitate under acidic conditions, and whey proteins which
remain in milk serum at low pH [163]. Caseins are a family of phosphoproteins which
constitute 80% total milk protein. Alpha and beta casein are serine phosphorylated to
permit interactions with calcium phosphate resulting in formation of micelle structures in
milk [164], These micelles transport calcium, inorganic phosphate, trace amounts citrate
and magnesium from mother to neonate. Beta casein is commonly identified in studies on
mammary epithelial differentiation in culture [165], However studies on knock-out mice
have shown that beta casein is not essential for mammary development or survival of
neonate [163]. Of the whey proteins, alpha lactoglobulin is present in the milk ofmany
species. It is involved in synthesis of lactose from glucose and galactose and is thought to
be a marker of late mammary differentiation [166], In the rodent mammary epithelial
model, an alternative late differentiation marker is the cysteine rich whey acidic protein
(WAP) [166].
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It has been demonstrated that premature overexpression ofWAP results in disruption of
the differentiation programme and structural development of rodent mammary gland
[167]. Rodents also produce lesser amounts of the whey protein beta lactoglobulin (BLG)
in their milk, however its function remains unclear [168], Both the BLG and WAP
promoters have been used to target the mammary gland in transgenic animals [93, 169],
An alternative more contraversial marker of mammary differentiation is mammosphere
formation, which occurs when mammary epithelial cells are cultured on extracellular
matrix with lactogenic hormones. These mammospheres are thought to resemble alveoli
in vivo, and one group has proposed that they are a prerequisite for WAP secretion in this
system [170],
Serum-independence, anchorage-independence and tumourigenicity
As discussed earlier normal cells in tissue culture proliferate until they form a monolayer
and show contact inhibition. The particular density at which they stop proliferating seems
partly dependent on the serum concentration of the medium, which provides necessary
growth factors [171 ]. If normal cells are plated at a lower density in the same serum
concentration, they again proliferate to a certain saturation density. Although intuitively one
would expect immortalization which extends the lifespan of normal cells to increase the serum
requirement of cells, this appears not to be the case [172], In contrast, transformed
cells show an increased saturation density and a reduced serum requirement [173].
Growth in a serum-free or low serum environment is a recognised feature of transformation
cells in culture. It is clear from the literature that there is a relationship between factors
controlling growth ie serum-dependence and those controlling adhesion to matrix ie
integrin-mediated anchorage-dependence [174, 175]. Early experimental evidence
showed that oncogenes could activate integrin-mediated pathways in suspended cells-
which are anchorage-independent [176], One proposed model is that oncogenes can
constitutively activate pathways before or after convergence of serum-dependent and
anchorage-independent pathways [177]. Thus activation before convergence results in
either anchorage or serum-independence in transformed cells. However, activation after
convergence would result in transformed cells that were both anchorage and serum-
independent. To an extent this model is supported by experimental evidence. For example
overexpression or activation of oncogenic rho, FAK, CDC42, ILK and c-abl results in
cells that are anchorage-independent but not serum-independent [177].
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Activation of pathways by v-fos,v-Ras , v-src and SV40 large T antigen results in
transformed cells which are both anchorage and serum-independent [177]. To date, there
is no evidence for oncogenic activation causing serum-independence only without
anchorage-independence. Anchorage-independence is assessed formally in vitro by the
ability of cells to form colonies in a semi-solid medium-usually soft agar [ 178]. Most
normal cells will not proliferate in suspension, with the exceptions of blood cell
precursors and chondrocytes, both of which are in suspension in vivo [179]. Several
studies have correlated the ability to grow in suspension eg growth in soft agar, with
tumourigenicity in immunodeficient mice [180, 181]. Since many cell lines are derived
from non-inbred animals which may elicit an immune response in a mouse from a
different background it has become necessary to assay cellular tumourigenicity, in
immune suppressed animals. Further more, even if a cell line is descended from an inbred
strain, it may express a new cellular antigen and then elicit immunologic rejection when
injected into the animal of origin.
Immunodeficient mice fall into two broad categories the nude or scid (severe combined
immunodeficiency) mouse. The nude mouse lacks a thymus congenitally [182] and is
deficient in thymus-dependent immunologic functions [183]. Nude mice can support the
growth of certain human tumour transplants as well as a wide range of xenogeneic skin
grafts [184]. Injection of certain malignant tumours can give rise to metastasizing
tumours in nude mice. Mice homozygous for the scid mutation are severely deficient in
functional B and T lymphocytes [109]. The mutation appears to impair the recombination
of antigen receptor genes and thereby cause an arrest in the early development ofB and T
lineage-committed cells: other haemopoetic cell types appear to develop and function
normally. Young adult mice are leaky and generate a few clones of functional B and T
cells [185]. By 10-14 months all mice are leaky. Scid mice support the growth of
allogeneic and xenogeneic tumours [109]. However transplantation of rat and human
mammary carcinomas into the mammary fat pad has been unsuccessful, with an
acceptance rate less than 15% [186]. The reason for this unclear, however it has been
shown that the take rate can increase to 50% with the coinjection of Matrigel, a mixture
of extracellular matrix molecules which enhances both tumour growth and metastasis [96,
187],
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Although the ability to form tumours in immunodeficient nude athymic or scid mice
seems an attractive gold standard for assessing transformation, it only assays for one
aspect of malignancy, namely uncontrolled proliferation. A serious weakness in this
assay is that it fails to demonstrate the complex in vivo properties of malignancy, namely
invasion and metastasis. Indeed the 'normal' HC11 mammary cell line forms tumours
when injected into immunodeficient animals, but it is unlikely to metastasise [88]. One
assay of metastasis, is to score cell lines by their propensity to seed in various organs of
an immunodeficient mouse. For example a melanoma line metastasizing to lung is easy to
detect because of the characteristic pigment of the metastatic deposits [188], This is a
time and animal intensive approach and alteratives are still being sought. One cell culture
approach used in lymphoma cells is to monitor their ability to infiltrate monolayers of
hepatocytes or fibroblasts [189], This feature apparently correlates well with the ability of
lymphoma cells to form experimental metastases.
Chromosome content
Apart from assessing the biological characteristics mentioned previously, it is possible to
assess cell lines in terms of chromosome and DNA content [190], For example, DNA
flow cytometry has been used to show that continual passage in cell culture results in
alterations in DNA content. Furthermore, immortalisation procedures, in particular the
addition of a viral antigen to cell lines may affect their chromosomal content. However in
broad terms transformed cells or tumour populations are more likely to show aneuploidy
than normal cell populations [190, 191]. Karyotype analysis is one method to identify the
gross chromosomal aberrations in normal versus transformed lines [192], An alternative




The choice of method for transferring DNA into target cells depends to a large extent on
the research setting, the nature of the target cell and the degree to which the DNA
construct is required to integrate with host DNA. Broadly speaking the choice lies
between non-viral and viral methods, and the processes are termed transfection and
transduction respectively.
The non- viral approaches in general terms rely on using the ability of the cell to
phagocytose foreign molecules, increasing the permeability of the cell membrane or
direct physical transfer of DNA into the cell. A routinely used non-viral method, is
transfer ofDNA to the target cell using calcium phosphate precipitation [188]. It is
thought that co-precipitation of the DNA construct with calcium phosphate results in
phagocytic uptake by target cells, although the precise chemical mechanism of this is
unclear. Using modifications to the originally described procedure, high transfection
efficiencies have been described. An alternative method using DEAE dextran with
chloroquine, is useful in transient transfections requiring the analysis of large numbers of
DNA constructs [188]. The DEAE dextran is mixed with the DNA construct and overlaid
onto target cells, resulting in expression of the DNA within 24-48 hours. At chemical
level, it is thought that the chloroquine neutralises the pEI of lysosomes preventing
degradation ofDNA en route to the nucleus. However a number of studies report higher
rates of DNA mutagenesis in DEAE dextran transfections compared with calcium
phosphate [194], Lipid- based techniques, in particular cationic liposomes, utilise the
phagocytic capabilities of the target cells, similar to calcium phosphate and dextran [195],
Fatty droplets containing the DNA construct are engulfed into the cell. This approach has
had success in gene therapy research, particularly with respect to cystic fibrosis [196].
The electroporation approach, in contrast to calcium phosphate and DEAE dextran,
involves exposing a cell suspension with added DNA construct, to a high voltage electric
field [197]. The field is thought to create large pores within the cell membrane, to allow
the DNA to enter the cytoplasm. A proportion of this DNA enters the nucleus to stably
integrate with the host cell genome, however the dynamics of this process are unknown.
24
The target cells are incubated at low temperatures in order to reseal their membranes.
Similar to electroporation, chemical detergents can also partially disrupt target cell
membranes to make it more them more permeable to DNA constructs, however they have
been shown to also damage intercellular membranes [197],
The physical approach involving direct transfer ofDNA into individual target cells via
a micropipette, is termed microinjection. This approach has been used in a number of
studies, however it is limited in that only a few hundred cells can be examined at one
time. A significant problem encountered by all non-viral systems is that certain cell types
such as epithelial cells, primary cell culture sytems and cells in suspension have
intrinsically low transfection efficiencies. The reasons for this are still unclear
Viral techniques of gene transfer involve inserting DNA constructs into viral vectors, to
utilise the viral method of entry into the cell and possible integration with the host
genome. These techniques provide a useful, but perhaps more technically demanding
alternative to the non-viral methods discussed. However, an overriding concern when
using this technology is to prevent uncontrolled infection of target cells. This is achieved
by engineering replication-defective viral vectors [198], which are most frequently
adenoviral or retroviral. Alternative vectors include adeno-associated virus (AAV),
herpes virus, vaccinia virus and several RNA viruses [199],
Adenoviral-mediated transfer is a routinely used technique, which has achieved high
transduction efficiencies particularly in transient assays [200]. Although integration of
adenoviral DNA with target cell DNA can occur, it is relatively inefficient because stable
integration is not part of the adenoviral life cycle. The adenoviral vector has an advantage
over retroviral methods, with the exception of lentiviral vectors, in that it can be used to
transduce non-dividing cells [200], The most critical advance in the development of
adenoviral vectors has been the observation that replication-defective adenoviruses
lacking portions of the El region of the viral genome could be propagated by growth in
cells engineered to express the El genes [201]. Since then it has been shown that
replication-defective adenoviral genomes carrying foreign DNA sequences can be
propagated in the same way.
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The main alternative category of viral vector is the retrovirus [202], The main advantage
over adenovirus, is that retroviral DNA stably integrates into the target cell genome in a
defined manner, so that the gene introduced is passed on and expressed in all daughter
cells [199]. Retroviruses contain elements which enhance transcription, therefore
promoting high levels of gene expression in all target cells [203]. Certain vectors have
been reported to achieve stable transduction of close to 100% of target cells [198].
Experimentally, retroviruses have small genomes compared to adenoviruses and therefore
can be easily manipulated to introduce foreign genes, however this does limit the size of
DNA which can be transduced. Recently it has been shown that high titres of retrovirus
can grown relatively easily in cell culture [204],
The principle of vector technology depends on harnessing and manipulating the normal
retroviral lifecycle. The defining step of the lifecycle of the retrovirus family, is the
conversion of their RNA genome into DNA by a virus- encoded reverse transcriptase
[199], The retrovirus consists of two copies of a single- stranded RNA genome
surrounded by a glycoprotein 'envelope'. These surface glycoproteins interact with
receptors on the surface of the target cell, in order to gain entry [205], When inside the
cell, the single-stranded viral genome is converted into a linear double-stranded DNA by
a virus- encoded reverse transcriptase. As the target cell undergoes mitosis, the viral
DNA integrates randomly with the target cell DNA- at which point it is known as a
provirus [206]. It is this proviral DNA which is manipulated to form retroviral vectors for
gene transfer. The provirus then undergoes transcription and translation with the rest of
the genome, resulting in the assembly of new viral particles which bud off the surface of
the target cell in order to infect others.
The single most important advance in the development of retroviral vectors has been the
development of the packaging cell which allows the assembly of virus particles with the
gene of interest [198]. This packaging- cell method reduces the liklihood of producing a
virus that is replication competent and therefore able to infect cells in an uncontrolled
fashion. Nevertheless rare 'outbreaks' ofwild-type virus from recombinant virus-
producing packaging cell lines have been reported. In a primate bone marrow
transplantation experiment which targetted haemopoetic cells, stocks were contaminated
with replication-competent virus resulting in several of the transplanted animals
developing lymphomas [207],
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The principles behind choosing a particular packaging cell line are based on the
probability of producing contaminating replication competent virus, the desired host
range of the virus vector and the required titre of the virus vector. Several Murine
Leukaemia Virus-based (MLV) packaging cell lines which are typically fibroblast
derivatives, are available which have been modified to improve safety an prevent
recombination events [198], They contain sequences of independently coding DNA
sequences known as DNA plasmids, that express viral gene products. The viral gene
products include: gag- group antigen polyprotein, Pol-reverse transcriptase and Env-
envelope protein [199], In these systems viral genes are deleted for cis-acting sequences
at the 3' end to reduce homology between helper and vector sequences and gag-pol and
env are present on separate plasmids, having been transfected sequentially.
The system which is used in this study is based on the Nolan Stanford University
Phoenix system (www.leland.stanford.edu/group/nolan) and is represented in Figure 1. It
differs from other packaging cell lines in that it is not a stable cell line. In terms of
procedure, the first step involved in gene transfer is the modification of the retroviral
vector so that it contains the gene of interest. This vector is then transfected into the
packaging cell line, using traditional non-viral DNA transfer techniques.
When the vector is introduced into these packaging cells, it is packaged into virus
particles by means of the gene products just described. These virions bud off into the
culture medium and are placed on the dividing target cells. The crucial event in infection
appears to be the attachment of the viral particle to a specific cell- surface receptor [205].
This is followed by a complex set of comformational rearrangements which triggers
fusion between viral and cytoplasmic lipid bilayers. The viral vector stably integrates into
the target genome, and then expression of the gene of interest is passed to daughter cells.
In order to target retroviral vectors to a specific cell type, two strategies can be adopted :
i) allow infection of all cell types and regulate gene expression at a transcriptional level
through tissue specific or inducible promoters[208] or ii) manipulate cell surface receptor
so that regulation is introduced at the level of infection.
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Safety considerations are very important when using this technology, as the main hazard
is the product of a replication- competent virus which can infect humans. One way of
combatting this is to use an ecotrophic virus, which means that virions can only infect
mouse and rat cells, due to the specificity of their cell surface receptors [205], In contrast,
amphotrophic viruses have a range of hosts including bird, rodent, mammal and human
[16], and their use is more hazardous.
Another potential problem with the system is recombination of the plasmids producing
viral gene products in the packaging cell. In order to assess this, an added feature in the
packaging cell plasmids is an Internal Ribosomal Entry Site or IRES sequence [209], The
IRES sequence ensures that the Gag and Pol are transcribed together with CD8. This
means that packaging cells can be sorted by CD8 on a FACS machine, thus checking the
integrity of the plasmids expressing Gag and Pol.
The Nolan system has been further modified for a high efficiency, so that from
transfection of packaging cells to infection of target cells takes approximately 48 hours
[209], The modification uses the Epstein Barr virus which has been used to maintain
retroviral vectors episomally ie outside the genome, within human-based packaging cell
lines [210], This system results in a much higher output with titres of virions as high as
107 Colony Forming Units per ml, produced for atleast 30 days. Alternative, less efficient
systems include a tetracycline- regulated system for allowing inducible gene expression
using retroviral vectors [208],
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Many studies have effected a reversion of the transformed state to a normal cellular
phenotype in cell culture. In general they involve manipulation of E-cadherin, alternative
components of the junctional complex, integrins or cytoskeletal assembly [212], More
upstream regulators include nm23, the E1A viral antigen, and Tiaml [214, 216, 238]. It
has also been demonstrated that the introduction of chromosomes, in particular human
chromosome 6, can have a similar effect [220, 223-225].
Direct evidence about the importance of E-cadherin has been demonstrated in a number
of discrete epithelial cell systems, including mouse mammary gland, and under different
oncogenic stimuli including Ras and MMTV [211]. Results have shown that highly
invasive epithelial tumour cells can be rendered noninvasive by the introduction of a
single E-cadherin cDNA, and that invasion can be reinstated by treatment of such
transfected cells with monoclonal anti-E-cadherin antibodies [212], Moreover,
invasiveness could be induced in noninvasive cells by downregulating the endogenous E-
cadherin expression with antisense RNA [212, 213]. As E-cadherin has been implicated
in the Tiaml pathway of reversion it will be discussed later in more detail.
Candidates for upstream regulators of the reversion pathway remain more speculative.
The nm (nonmetastatic) 23 gene is one such putative, suppressor gene which was
originally identified with reduced expression in highly metastatic cell lines [214].
In vivo evidence has shown that expression of nm 23 is reduced in breast cancer patients
with lymph node metastasis, and furthermore that loss of nm 23 mRNA is associated with
poor survival in breast cancer patients [215]. Experimentally, introduction of nm 23
cDNA into metastatic murine melanoma cells reduces their metastatic potential [214], It
appears that the nm 23 gene is a nucleoside diphosphate kinase which is involved in
microtubule organisation and signal transduction through G proteins [214], It has been
proposed that genetic instability in metastatic cells may result from reduced nm 23,
allowing aberrant mitosis to occur on an aberrant mitotic spindle. This model does not
explain the phenomenon of supression of invasive cell-lines, which have already
sustained numerous genetic abnormalities.
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More recent studies aimed at discovering events upstream, have shown that certain
adenovirus ElA proteins can revert the transformed phenotype of a wide variety of cell
lines, including those transformed by Ras and erbB/neu oncogene [216], This is
remarkable because the El A protein was first identified as a viral product that could
immortalize primary rodent cells, and transform them in cooperation which a second
oncogene-including Ras [218].
However there is no evidence to suggest that El A plays a role in any human cancers
[217], The primary function of the El A viral protein in the normal lifecycle is to activate
viral gene transcription as well as re-program cellular gene expression to support viral
replication. This ability to re-program, allows El A to both activate and repress gene
transcription, as well as induce entry and passage through the cell cycle, and block
dedifferentiation. Detailed analysis of the protein has identified regions which are
responsible for suppression of transformation, tumourigenicity and metastasis [216], It
has been proposed in the case of phenotypic reversion of lines transformed by c-erb2, that
ElA mediates repression of c-erb2 transcription occurs through pRb binding [218]. In the
case of suppression ofRas transformation, a protein known as CtBP which has homology
to enzymes of D-2-hydroxy acid dehydrogenase family, may modulate the activities of
other proteins bound to the transforming regions of the same El A molecule [216].
Another interesting observation is that expression ofEl A in human A204
rhabdomyosarcoma cells induces transcription of E-cadherin, although the region
responsible for this is unclear [219], El A also represses the expression ofmatrix
degrading proteases through the AP-2 transcription factor, and represses expression of
CD44 adhesion molecule, which could help inhibit metastasis. Moreover, ElA can
induce expression of nm 23 [216].
Diverse phenotypes may be obtained upon the introduction of different chromosomes
into a cell line. These include in vitro growth supression, in vivo tumour suppression and
the induction of terminal differentiation [220, 221] The induction of in vitro growth
suppression may represent replicative senescence ie the cells remain metabolically active
but cease to proliferate [222]. In murine breast cancer cells chromosome 6 causes growth
suppression [223].
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There have also been reports localising the growth suppressor activity in human MCF7
breast cancer cells to chromosome 17q24-25 [224]. Interestingly the introduction of
human chromosome 6 into human melanoma cell lines results in microcell hybrids which
have lost their ability to form tumours in nude mice [225], and the subsequent loss of
chromosome 6 in the hybrids results in reversion to a tumourigenic phenotype. Further
analysis of model by DNA chip analysis has identified significant differences in gene
expression between wild-type and reverted melanoma cells; however the biological
significance of these differences requires exploration [226, 227].
Tiaml
Tiaml which stands for T lymphoma invasion and metastasis gene, is a guanine
nucleotide exchange factor for Rac, a member of the Rho GTP ase family [228], Rho
GTP ases have emerged as key regulators of the cytoskeleton, and through interaction
with target proteins can mediate gene transcription and cell adhesion [229],
As its name suggests Tiaml was originally described as an invasion-inducing gene in
lymphoma cells. It was identified by insertion of provirus into lymphoma cell lines and
then selecting for those lines which became invasive [230], In 40% (12 out of 30) of
generated invasive variants, proviral insertions were found within the coding exons of the
Tiaml gene. These insertions resulted in the majority of cases with both truncated 5'- end
and 3'- end transcripts that gave rise to N- and C- terminal Tiaml protein fragments. In
one invasive variant, there was an amplication of the Tiam 1 locus with an increase in
normal protein levels. It is clear that truncation of other members of the guanine
nucleotide exchange factor family such as vav, Dbl and Ect-2 are also required for
oncogenic potential [230]. At a functional level, the truncations result in C-terminal
Tiam-1 proteins which lackN-terminal PEST domains and a potential myristorylation
site (Figure 2). This could result in increased protein stability and or affect their
subcellular distribution. It is clear that the N-terminal Pleckstrin homology domain is
required for targetting Tiaml to the plasma membrane [231, 232], This domain also
appears necessary for Rac- dependent membrane ruffling and c-jun NH2-terminal kinase
activation [233]. Experiments to date with Tiaml use the stabilised, truncated protein.






Figure 2 Tiam 1 constructs showing control C580 Tiaml
active CI 199 Tiaml
Tiaml and the truncated constructs are shown schematically in Figure 2. PHn and PHc
represent NH2 and COOH Pleckstrin homologous domains which are present primarily
insignaling molecules are thought to determine the cellular localization and/or activity of
the protein by interacting with proteins or phospholipids [235].
DHR represents Discs-Large homology regions which have been implicated as protein-
protein interaction motifs [236]. DH represents a Dbl homology domain, which is present
in guanine nucleotide exchange protein and is considered to be the catalyic domain [237],
M--P represents a potential myristorylation signal and PEST sequences.
Transfection of truncated Tiaml constructs increases the oncogenic potential of
fibroblasts, similar to lymphoma cells [234]. The precise mechanism of this remains
unclear. However it has been suggested that Tiaml via Rac, effects changes in the
cytoskeleton and promotes adhesive contacts between cell and its environment, thus
promoting invasion. Certainly ectopic Tiaml expression results in striking morphological
and cytoskeletal changes, including flattening of cells and membrane ruffling [238], In
neuroblastoma cells, Tiam 1 promotes adhesion and spreading, possibly mediated by
recruitment of the alpha 6 beta 1 integrin, which is a laminin receptor [239]. The potential
importance of Tiaml and interactions with the environment in neuronal cells, has been
highlighted during murine central nervous system development where the gene is
differentially expressed [240, 241], However, the notion that Tiaml is an oncogene, may
be questionable because in epithelial cells, truncated Tiam 1 contructs suppress invasion.
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In transformed Madin Derby Canine Kidney (MDCK) epithelial cells, ectopic expression
of Tiaml results in localisation of Tiaml with E-cadherin at adherens junctions, a
remarkable phenotypic reversion to a normal epithelial phenotype, and loss of invasion
[242], These changes occur via Rac, which is involved in adherens junction assembly in
keratinocytes [229], One possible explanation for cell- type specific phenotypes with
Tiaml is the differing abilities of cells to form junctions with each other and with matrix.
During invasion, epithelial cells downregulate E-cadherin expression which mediates the
strong cell- cell junctions [243], This is not necessary in fibroblasts and lymphoma cells,
which do not have these junctions. After down regulation of E-cadherin, all cell types
modulate attachments via integrin receptors, in order to attach to the environment and
invade. It has been proposed that Tiaml inhibits invasion in epithelial cells by
upregulating E-cadherin, but promotes invasion in fibroblasts and lymphoma cells by
stimulating cell-matrix contacts; the outcome may be influenced by the type ofmatrix
present [244]. The idea that altering structure and cell adhesiveness, can overcome or
promote the main features ofmalignancy, namely uncontrolled growth and invasiveness
are not confined to cell culture models (discussed in section E-Cadherin).
The relevance of Tiaml in humans and mice in vivo remains unclear. Mouse Tiaml
maps to the distal end ofmurine chromosome 16, while the human homologue of Tiaml
maps to 21 q22, centromeric of the Ami (acute myeloid leukaemia ) gene. Both are 95%
identical at the amino acid level [245], In normal human and murine tissues Tiaml is
expressed at very low levels, except in brain and testis [245]. The reason for this
difference is still unclear, but presumably the low levels in most tissues are due to PEST
instability domains in Tiaml. In contrast, Tiaml is expressed in most human tumour
cell lines including those derived from breast carcinoma, lung, ovary, bladder, pancreas,
lymphomas, melanomas and neuroblastoma [245]. Whether Tiaml levels show any
association with invasive or metastatic capacity in human tumours remains to be
demonstrated. The suggestion that Tiaml is involved normally in cell signalling
processes, comes from its strong evolutionary conservation and broad patterns of
expression in normal tissues and tumourigenic cells [245]. Current knowledge of the
upstream and down stream components of the Tiaml signalling pathway remains limited.
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Upstream modulation of the family of guanine nucleotide exchange factors has been
reported to be either via phosphorylation or cellular relocalisation [246].
Rapid threonine phosphorylation ofTiaml in Swiss 3T3 fibroblasts is stimulated by
lysophosphatidic acid, a mitogen which is an important component of serum [246].
This occurs via protein kinase C. Other growth factors including platelet-derived growth
factor, endothelin-1, bombesin and bradykinin (but not epidermal growth factor ) have a
similar but reduced effect, without evidence of relocalisation of Tiam 1 in any case [246].
However when serum is added to NIH3T3 fibroblasts, Tiam 1 specifically relocates to
become associated with the membrane fraction [231], It is still not clear whether
phosphorylation of Tiam 1 or relocation to the membrane affects its nucleotide exchange
activity ofRacl.
The downstream activity of Tiaml which involves exchanging bound GDP for GTP on
Rac, has been observed in fibroblasts and MDCK epithelial cells, among other cell types
[230], Racl has been implicated in stress fibre formation in fibroblasts, as well as
interaction with other pathways controlled by the Rho family ofGTPases [247].
Members of this family have provided a link between growth factor signalling and
reorganization of the actin cytoskeleton, focal complex formation, endocytosis,
cytokinesis, Ras transformation and cell proliferation [229]. Most of these studies used
fibroblasts [229]. In terms of epithelial cells, recent evidence has demonstrated that Rac
and Rho in concert are necessary for the establishment of cadherin dependent contacts in
keratinocytes [229]. Most recent evidence has implicated IQGAP1 [248], a target of
Cdc42 and Racl, as a possible mediator of the effect on E-cadherin, using colocalisation
and inhibition assays [249]. In these studies, IQGAP needs also to associate with beta-
catenin to function.
E-cadherin
While Tiaml may play a role in general signalling, there is clear evidence that E-cadherin
plays a key biological role in tumourigenesis [243], The only other cadherin implicated is
H-cadherin which is lost in certain breast cancers [254]. As discussed earlier E- cadherin
physiologically forms part of adherens junctions, but may also be involved in
transduction of transmembrane signals which regulate gene expression.
Mutation or deletion of the CDHlgene coding for human E-cadherin or loss of protein
expression are seen amongst a host of human malignancies including breast, colon, lung,
stomach and liver [211].
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In familial gastric cancer, germ-line mutations in CDH1 alone are sufficient to promote
carcinogenesis [255], In cases where E-cadherin expression appears unchanged, other
components of the junctional complex may be affected, in particular mutations in the beta
catenin gene are found in colon cancers [256], Beta catenin is known to act as a
transcription factor for pathways promoting growth [257], Whether these growth
pathways are inappropriately activated when junctional complexes are disrupted during
carcinogenesis, remains contraversial [258], Less common mechanisms by which E-
cadherin activity is disrupted include chromatin rearrangement, hypermethylation and
loss of transcription factor binding [259-261],
Aside from tumourigenesis, E-cadherin is essential for development. Mice deficient for
E-cadherin die in utero because of defective development of the trophoectoderm [262],
The developmental process can be affected by the Rho family ofGTP ases [263], integrin
linked kinase [264], growth factor- receptor signalling [265] and matrix metalloproteases
[266], It has been suggested that misregulation of these processes is also involved in
tumourigenesis.
Consistent with the observation that loss of E-cadherin is biologically significant, it has
been demonstrated that restoration of E-cadherin function can suppress transformation in
a number of cell culture systems [211]. The question remained in the majority of cancers
in vivo whether loss of E-cadherin was causal or resulted as a consequence of tumour
progression. However an elegant approach using a transgenic mouse model for pancreatic
Beta cell carcinogenesis showed that crossing these mice with those that maintain E-
cadherin expression, halted the process of tumourigenesis at the adenoma stage [267].
Therefore unravelling the regulation ofE- cadherin expression remains a key question.
In addition to mutation and post-translational modification, changes in gene expression
may affect the phenotypic changes seen in culture and in vivo. For example
overexpression of c-erbB2 in mammary epithelial cells inhibits E-cadherin gene
expression, which may contribute to erbB2 oncogenic potential [268].
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It has also been shown that oestradiol regulates E-cadherin mRNA levels in the ovary
[269], In more general terms the epithelium-specific human papilloma viruses (HPV) 16
and 18 contain several binding sequences for ubiquitous cellular transcription factors, and
certain transcription factors such as NF1 show specificity of function with regard to
epithelial versus mesenchymal cell types [261]. It has therefore been proposed that a
variety of transcription factors could bind the E-cadherin promoter, although studies in
this area still limited [261].
In summary, therefore there are several biological features used to define epithelial and
mammary differentiation in normal cell lines, as well as assays to define transformation.
There are also a number of methods used to transfer genes into epithelial cells, of which
retroviral transduction is a useful option. Furthermore, one strategy to revert transformed
epithelial cells to a non-transformed phenotype involves expressing the guanine
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Study design
Characterisation of cell lines
To examine the two KIM2 cell lines derived in the Watson lab. termed NKIM2 and
TKIM2 respectively. These cells had been previously derived from transgenic mice
targeted with a temperature-sensitive ts a58 SV40 large T antigen, at 37°C and 33°C
respectively. In order to characterise the cell lines, they were assessed in terms of a
number of accepted biological markers at 37°C and 33°C respectively. The extent of
epithelial characteristics and mammary differentiation of the cell lines were studied: by
the cell morphology under phase and electron microscopy; the presence of other cell
types using myoepithelial and fibroblast markers; epithelial marker expression and
junctional presence; the presence of polarisation; and milk protein expression.
Furthermore, the extent to which cells were transformed was examined: by morphology
under phase and electron microscopy; serum starvation; growth in soft agar; injection into
scid mice; p53 and T antigen expression, chromosome spread, and FISH analysis of
chromosome 11 and chromosome 17.
Retroviral transduction
To use retrovirus to transduce the NK1M2 and TKIM2 cell lines with control and active
Tiaml, and confirm the expression in target cells.
Study of transduced cell lines
To the determine the effect of Tiaml on the four transduced cell lines in terms of the




KIM2 cells were derived by Katrina Gordon from transgenic mice with a fusion gene
consisting of 4.2 kb of 5' flanking promoter sequences, including the transcriptional start
site, of the ovine beta-lactoglobulin (BLG) gene and the temperature-sensitive variant of
SV40 large T antigen (tsA58) [94], The transgenic mice were derived from
microinjection of the fusion gene into pronuclear eggs from C57BL/6 x CBA F1 mice
after mating with male studs. The KIM2 cell lines used in this study were derived from
mammary gland explants from mid-pregnant transgenic mice, enriched for epithelial cells
and derived at the semi-permissive temperature of 37° C and 33 °C respectively. The cell
lines were maintained at 37°C and 33°C respectively, with a stable epithelial and spindle
morphology (over 60 passages), termed NKIM2 and TKIM2 respectively. Cultures were
grown on plastic in maintenance medium: Dulbecco's modified Eagle's medium
(DMEM) (Gibco-BRL), supplemented with 10% fetal calf serum, 5 pg/ml insulin, 10
ng/ml EGF and 5 pg/ml linoleic acid. Cells were passaged as clumps to help maintain
their morphology, and divided 1:3 or 1:4 every 3-4 days.
In order to induce differentiation in KIM2 cells, cells were grown on plastic until
confluent. After 2 days at confluency, lactogenic hormone induction media was then
added consisting of maintenance medium without EGF, supplemented with 2%
dexamethasone and 1% ovine prolactin. Cultures were maintained for up to 12 days with
media changes every 2 days.
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Retrovirus
Retroviral vectors were kindly supplied by John Collard and were based on the Nolan,
Stanford University Phoenix system. The development of these vectors is detailed
elsewhere [209], The episomal retroviral backbone is outlined in Figure 1.
The packaging cell system used in conjunction with the LZRS vector are NIH-3T3 cells
[282]as part of the Nolan, Stanford University Phoenix System [209] which produces




Figure 1 Retroviral vector backbone
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The oligo-polylinker for the LZRS-IRES-LacZ/Zeo/Neo constructs, which
allows the Tiaml constructs to be inserted into the retroviral backbone is shown
in Figure 2 (for reviews see [280, 281]).
sni
V f^VTCCATTTWAATTVXiAATTCCTGCAGGCCTOGAGGCCCCiGClK
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Figure 2 Retroviral Oligo-polylinker for LZRS-IRES-LacZ/Zeo/Neo constructs
Tiaml constructs
Tiaml constructs active CI 199 Tiaml and control C580 Tiaml were kindly provided by
John Collard. A schematic representation of the constructs is shown in Figure 3.
A full description ofTiaml constructs is available [234],
M--P




Figure 3 Schematic diagram of active C1199 Tiaml construct (expected size 160 kD)
and C580 control construct (expected size 81 kD)
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Antibodies
The antibodies used are listed below, with the relevant dilution, incubation period and supplier.
All were monoclonal with the exception of the polyclonal (3-casein antibody.
Dilution Incubation Supplier (clone)
primary
E-cadherin 1:1,600 1 hr room temp. Sigma (DECMA-1)
a- actin(smooth muscle)! :400 1 hr room temp. Sigma (1A4)
Vimentin 1:800 lhr room temp. Sigma (VIM 13.2)
p- casein 1:1000 1 hr room temp. Sigma (CAS-1)
SV40 large T antigen 1:400 1 hr room temp. Sigma (Pab-101)
Tiam-1 1:200 1 hr room temp. Santa Cruz (C-16)
ZO-1 1:400 lhr room temp. Santa Cruz (C-16)












The fluorescein conjugate for the secondary antibodies is fluorescein isothiocyanate
(FITC).
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Reagents and commercial suppliers
A list of general reagents and the addresses of the commercial suppliers is given below. Any
additional specific reagents are mentioned in context with the relevant supplier.
Reagents Supplier
Alcohol Fisons
Agar (Sea Plaque) Sigma
DMSO (dimethylsulfoxide) NBS biologicals
Eosin Sigma
Foetal calf serum Gibco
Goat serum Sigma
Haematoxylin Sigma




PBS (Phosphate buffered Saline) Sigma
Protease inhibitors Sigma
TBS (0.05M Tris-buffered Saline pH 7.5) Sigma
Trypsin (1 in 250) Difco
Xylene Fisons
HEPES: N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid)
Addresses of commercial suppliers:
Becton Dickinson UK Ltd. Between Towns Road. Cowley.Oxford.U.K.
Boehringer Mannheim GmbH. Mannheim. Germany
CAMBIO Drawer 1630, Silverthorne.USA 80498
DAKO Limited. 16 Manor Courtyard, Hughenden Avenue. High Wycombe. Bucks. UK
DIFCO Laboratories, Detroit. Michigan.USA
FISONS Scientific Equipment Ltd.. Bishop Meadow Road. Loughborough. UK
GIBCO Life Technologies Ltd., 3 Fountain Drive, Inchinnan Business Park, Paisley,
Pierce 600 Main Street, Bar Harbor, ME, USA.
OSWELL DNA service, University of Southampton, Boldrewood, Southhampton,UK
NBS Biologicals, New Brunswick Scientific (UK) Limited, Edison House, 163 Dixons Hill
Road, North Mymms, Hatfield, UK.
SIGMA UK Technical services, Fancy Road, Poole, DORSET, UK




Semi-quantitive detection of antigen expression was carried out by immunohistochemistry. Its
main advantage over more quantitative methods such as Western blotting is that the site of
expression can be visualised. The methodology used is based on the original description which
has been refined to use with an immunofluorescent secondary antibody [284],
Immunofluorescence is more convenient to use on fixed cells in terms of clarity ofmorphology,
as opposed to horse radish peroxidase techniques which are traditionally used on tissue sections.
The problem of fading of the immunofluorescent signal is overcome by addition of antifade
solutions (Sigma) prior to viewing. Where available all runs included a slide known to be
positive, (usually mammary gland). Furthermore all runs included a negative control by
omission of the primary antibody. Any run in which the positive control did not stain or the
negative control did stain was rejected. Exact controls are described in the appropriate results
section and all incubations were carried out at room temperature.
Cells were plated (1 x 103 cells) on slide flasks (Nunc) and washed in TBS (0.05M Tris-
buffered Saline ) for 5 minutes before fixing to remove any floating cells in the medium.They
were fixed with methanol: acetone at a ratio of 1:1 for 10 minutes and washed with TBS Ph 7.6
to remove any cell debris created during fixation. Non-specific antibody binding was reduced by
1 hour incubation in TBS + 20% Goat serum. Then cells were incubated with primary antibodies
(see Antibodies in Materials section) diluted as appropriate with TBS + 20% Goat serum.
Negative controls were incubated with TBS + 20% Goat serum only. After three 5 minute
washes in TBS + 20% Goat serum, cells were incubated with fluorescein-labelled secondary
antibodies, diluted as appropriate with TBS + 20% Goat serum (see Antibodies in Materials
section). After a further three 5 minute washes in TBS + 20% Goat serum only, antifade solution
was added to cells for 2 minutes, before the flask portion was detached from the slide flask.
After the addition of vector mount and coverslips to the slides, images were analysed by
fluorescence microscopy using a Zeiss microscope. Phase and fluorescence images were
recorded separately and subsequently merged. Slides were stored at -70°C.
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Electron Microscopy
Detailed introductions to the principles and practice of electron microscopy have been reviewed
[151, 285], The technique is useful for examining cell-cell contacts and ultrastructure.
The cells to be examined were grown in culture, trypsinised, spun and fixed in 3%
glutaraldehyde in 0.1 M Sodium Cacodylate/HCL buffer pH 7.2-7.4 at
4 °C for 48 hours. The subsequent processing of electron microscopy sections was carried out by
Frank Donnelly (F.D.). After washing with deionised water for 20 minutes, the samples
underwent secondary fixation in 1% Osmium Tetroxide in deionised water for 45 minutes at
room temperature. Samples were then dehydrated with methylated spirits and absolute ethanol,
before linking to propylene oxide for 10 minutes and impregnation in Emix resin (supplied by
Fison's, Leicester) overnight at room temperature. After polymerisation for 18-24 hours at 70
°C, 90 nanometer sections were mounted on 300 mesh copper grids and stained using the uranyl
acetate/lead citrate method. Finally sections were examined and photographs taken using a Jeol
100CXXII Transmission Electron Microscope. The results were examined in 100 electron
microscopic fields.
Cell counting for estimation of growth kinetics
For cell counting a standard hemocytometer was used, consisting of two chambers in which each
chamber is ruled into 9 major squares. When coverslipped the volume of each square is 0.1 mm1
or 1.0 x 1O^1 m. Cells were trypsinised and resuspended in maintenance medium. Using pasteur
pipettes two aliquots of cell suspension were delivered into each side of the coverslipped
haemocytometer by capillary action. The total number of cells in 5 of the 9 large squares in each
of the two sides of the haemocytometer were counted. Cells that overlapped two sides of the
square were included in the count and not counted on the other two sides. The number of cells in
a total of 10 chambers were added to give the number of cells in 1 x 10"3 m. The total number of
cells was multiplied by 1000 to give the number of cells per ml in the sample counted. Each
growth experiment was repeated on three independent occasions.
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Western blot analysis
Western blot analysis to determine the relative levels of protein expression in cell samples
was carried out was performed according to standard protocols, based on a description by
Laemmli (1970) [325].
Sample preparation
Cells were washed and scraped in 5ml ice cold PBS (phosphate-buffered saline)/ sodium
vanadate (ratio of 1:1) in order to prevent protein degradation. The cells were then spun
at 1000 rpm for 5 minutes to disrupt cell membranes, the supernatant was aspirated and
discarded, and the pellet snap frozen in liquid nitrogen and stored at -70°C until assayed.
In order to prepare protein samples, the pellets were defrosted and 200ul RIPA buffer
(see below) added, then vortexed until the pellet was dispersed. The DNA in the sample
was sheared by passing cells 3 times through a green needle (21G) or smaller and
transferring cells to an eppendorf. The cells were spun at 10,000 rpm at 4°C for 15
minutes, the supernatant removed and aliquoted. The protein concentrations of the
samples were determined using the BCA Protein Assay Reagent kit (Pierce) so that
samples with equal concentrations could be compared on gel electrophoresis.
SDS-PAGE
One dimensional SDS-PAGE (sodium dodecyl sulfate -polyacrylamide gel
electrophoresis) in 10-15% polyacryamide gels was performed with a 3% stacking gel
[325]. Proteins were transferred from gels to nitrocellulose filters at a current of
0.8mA/cm2 for 1-3 hours using a transfer kit or a semi-dry electroblotter.
After blocking non-specific binding (endogenous peroxidase) with 1% BSA (bovine
serum albumen) in TBS/ Tween (0.1 %) overnight, the nitrocellulose filter was exposed to
primary antibodies eg primary P- casein, Tiam 1 or E-cadherin at a dilution 1: 5000 in
blocking solution, for 45 minutes. Filters were then washed twice for 7 minutes with
TBS-T (Tween 0.05%) and incubated with horse radish peroxidase-conjugated secondary
diluted 1: 800 with blocking solution for 30 minutes. The filters were further washed with
TBS-T for 3 x 5 minutes and incubated with ECL reagents for 1 minute. Filters were then
processed in the dark room and bands visualised.
RIPA buffer: 50mM Tris HC1 pH 7.5, 150mM NaCl, 1% Nonidet p40, 0.5% sodium
deoxycholate 0.1% SDS in water, and stored at 4°C. Immediately before use the protease
inhibitors aprotinin lOug/ml, pepstatin luM, leupeptin 1 uM, sodium vanadate ImM and
phenylmethylsulfonylfluoride (PMSF ) ImM were added to the RIPA buffer.
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Chromosomal analyses
The isolation of metaphase chromosomes allows both biochemical and morphological
analysis.The method used attempts to maintain in vivo chromosome structure without
perturbation by using semi-physiological conditions, similar to that described by Lewis
and Laemmli 1982 [326].
Preparation ofmetaphase spreads for chromosome counting
and FISH analyses
Cell cultures were fed 24 hours before harvesting to achieve partial synchronisation and
then harvested when approximately 50% confluent and thus in log phase growth.
Two hours before harvesting colcemid (Boehringer Mannheim) was added to the culture
medium to a final concentration of 0.1 micrograms/ml, in order to arrest cells in mitosis.
Cells were then harvested and spun down at 1000 rpm for 5 minutes. The pellets were then
gently resuspended in hypotonic 0.075M KC1 to promote cell swelling and incubated for
four minutes at room temperature. Cells were re-centrifiiged and gently resuspended in a
single drop of supernatant before fixing by the addition of 10ml of ice-cold fix
(60% methanol, 40% glacial acetic acid). The cell suspension was left on ice for 30
minutes, centrifuged and resuspended in 5ml of fresh fix to assist the dissociation of
mitotic complexes. After five minutes on ice, the cell suspension was spun again and
resuspended in a smaller volume of fix (depending on the cell density).
Glass slides were prepared by washing in 70% ethanol, rinsing thoroughly in tap water
and storing in double distilled water (DDW). Three drops of the cell suspension was
dropped onto each slide from a height of approximately 40cm, and the slides air dried.
Slides were stored in a dessicator and the metaphase spreads viewed with a light microscope
within one month.
Chromosome counts
For chromosome counts, slides were stained in 5% Giemsa prepared in PBS. Twenty
metaphase spreads were selected at random and the number of chromosomes counted in
each spread, and counts were repeated three times on each slide.
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FISH analysis
FISH (fluorescence in situ hybridisation) analyses were performed using a biotinylated
murine chromosome 11 and 17 paint (Cambio) [134], Chromosome paints often contain
repeat elements that can be used to detect clustered repetitive DNA in heterochromatin
blocks and centromeric regions of individual chromosomes, and therefore are particularly
useful in determining numerical chromosome aberrations.
Specimen preparation
Glass slides with metaphase spreads were warmed at 60°C for 30 minutes and denatured
in 70% formamide at 65 °C for two minutes, before being dehydrated through ice cold
70 %, 90% and 100% ethanol for 2 minutes each. Then the slides were air dried,
prewarmed to 42°C and briefly vortexed.
Paint preparation
The chromosome paint was denatured at 70°C for 8 minutes and pre-annealed at 37°C for
15 minutes. Whilst the paint was pre-annealing, coverslips were prewarmed to 37°C. 15
pi of the paint was pipetted onto each coverslip.
Hybridisation
The coverslips were lowered onto the slides with metaphase spreads and sealed with
rubber solution. Slides were then incubated overight at 37°C. The rubber seal was
removed from the coverslip and the coverslip allowed to fall off in the first wash. Slides
were washed 4 times, for 3 minutes each in 2x standard sodium citrate solution (SSC),
50% formamide at 45°C. Then a similar wash was performed in 2x SSC only, before
slides were transferred to 4x SSC, 0.1% Tween 20.
Detection
Freshly prepared, 40 pi aliquots of avidin FITC, biotinylated anti-avidin and blocking
buffer were spun for 15 minutes at 4 °C to remove antibody conjugates. Each specimen
slide was incubated for 5 minutes, at room temperature, with 40 pi of blocking buffer.
The blocking buffer was replaced with 40 pi of avidin FITC, and slides incubated for 30
minutes at 37°C. Then slides were washed 3 times, for 2 minutes each in 4x SSC, 0.1%
Tween 20 at 45 °C, before incubation with 40 pi of biotinylated anti-avidin for 30
minutes, at 37°C. The wash process was repeated, and the slide incubated for a further 30
minutes with 40 pi of avidin FITC. Finally, the slides were washed and mounted with
40pl of vectormount, for viewing by fluorescence microscopy.
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Retroviral transduction
The retroviral system used was the Phoenix system [209] which had been modified and
produced by R.K. at the Netherlands Cancer Institute. Transduction of the Tiaml cells
was carried out with substantial help from and under the supervision ofR.K .
Packaging cells were passaged in hygromycin and diptheria toxin one week before
transduction and sorted by FACS for expression ofCD8 and surface expression of
envelope protein with 83A25 antibody, to ensure that plasmids had not undergone
recombination (see Introduction). The whole transduction procedure took 4 days.
Day 1 Packaging cells were plated in producer growth media containing DMEM, 10%
FCS, 1% Penecillin-Streptomycin, 1% Glutamine. Cells were maintained at
subconfluence because confluency reduces their transfection efficiency.
Day 2 Packaging cells were transfected with the Tiaml DNA constructs using calcium
phosphate precipitation:-
Preparation ofDNA
Firstly, DNA was prepared in HBSS (Hank's balanced salt solution) immediately before
transfection: 5-10 pg DNA was added in a dropwise fashion to a 15 ml tube at room
temperature. 438 pi of double distilled water was added to wash the DNA to the bottom
of the tube and 61 pi 2M CaCl2 was added and mixed thoroughly by finger tapping.
Then 0.5ml of 2x HBSS (see below) was added quickly and bubbled vigourously with an
automatic pipettor for 3-15 sees.
Transfection ofDNA into packaging cell line
Chloroquine was added to the Phoenix packaging cell line 5 minutes before transfection
to inhibit lysosomal DNAases, by neutralizing vesicle pH.
The HBSS/DNA solution was then added dropwise onto the media gently and quickly.
After adding the HBSS/DNA to the media very small black particles were visible under
the light microscope. The plate was put in a 37°C incubator and rocked a few times to
ensure even distribution of the DNA/CaP04 particles.
2x HBSS: 8.0g NaCl, 6.5g HEPES (see Reagents) and 10ml Na2HP04 stock solution
(5.25g in 500ml water). The pH of the 2 x HBSS was adjusted to 7.0 using NaOH or HC1
and the volume adjusted to 500mls.
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Day 3 Target cells were infected with the retroviral virons containing Tiaml constructs.
The target cells had been prepared so that they were subconfluent, in a dividing state.
The supernatant from transfected packaging cells containing virions was pipetted into a
15ml tube and centrifuged at 1500 rpm for 5 minutes to pellet cell debris.
1 ml of media was removed from each target cell plate and 3 pi of polybrene (lOOx at 5
mg/ml) added to each plate to assist uptake of the virions. 1ml of viral supernatant was
then added to each plate at 37°C with gentle shaking.
Day 4 24 hours post infection the media was removed and fresh DMEM and 10% fetal
calf serum was placed on the target cells at 37°C.
Day 5 The cells were assessed for morphological change, 24-48 hours post infection
because the actual process of reverse transcription and integration takes place within 24-
36 hours, depending on cell growth kinetics.
Anchorage-independent growth
The principle of the assay was to suspend the cells in soft agar and monitor their growth
in suspension [180], This involved suspending a top layer of agar containing cells on a
bottom layer of agar only, to prevent cells obtaining sites for anchorage. A cell
suspension was prepared at 104-l 03 cells per ml in media, and kept at room temperature.
The bottom layer of agar was prepared by adding 1.5% agar to double distilled water
(100ml total voume) at 44°C in a water bath for 30 minutes. Then 33ml of the heated
agar was added to a 100 ml medium mix (50ml 2x maintenance medium, 10ml 10 % fetal
calf serum and 7 ml double distilled water). The solution was mixed well and 15mls
poured into 6cm glass petri dishes, and allowed to set at room temperature for 30
minutes.
The top layer of agar was prepared by adding agar to the cell suspension at 2:1. 1,5ml of
this was poured onto the set bottom layer in the petri dishes. The dishes were fed with
maintenance medium (2ml) every two days. Colonies were counted using after 7 to 14
days when they were approximately 5 mm in diameter.
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Injection of scid mice
These studies were carried out with the help and guidance of Alison Ritchie.
Matrigel
Matrigel had been previously thawed overnight at 4° C, aliquotted (250pl) on ice into
precooled microcentrifuge tubes and then frozen at -20°C until ready for use [187]. All
procedures involving Matrigel were carried out on ice to prevent polymerisation.
Cells
KIM2 cells had been grown in maintenance medium in 75cm2 flasks until near
confluence. The medium was removed and cells were washed in PBS and cells were
harvested using trypsin (5ml). The cell suspension was transferred to a universal
container and 20ml DMEM /10% fetal calf serum was added to deactivate the trypsin.
The cells were then centrifuged at 2,500 r.p.m. for 5 minutes to obtain a cell pellet and
the supernatant was discarded. The cell pellet was then resuspended in DMEM minus
fetal calf serum and the cell number counted on a haemocytometer. The cell number was
adjusted to 5 xlO7/ ml. Cells were then resuspended in 250pl DMEM (minus fetal calf
serum) chilled on ice, and made up to 500pl with Matrigel before being injected.
The cell suspension (100 pi) was injected subcutaneously into both flanks of a female
scid mouse (Dept. Oncology) at 4-6 weeks of age. All mice were regularly examined for
tumour development for atleast 4-5 months following the injection.
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This section reports the data obtained by cell culture of original K1M2 cell lines before
genetic manipulation, in order to determine the epithelial and mammary characteristics
of the lines. Most of the data refers to normal K1M2 cells (NKIM2) derived and grown
at 37°C, and NK1M2 cells stimulated to show mammary differentiation with lactogenic
hormones (NKIM2-diff). The data referring to transformed KIM2 cells (TKIM2),
derived and grown at 33°C are shown in more detail in section 2 (Transformation). All
the data presented are consistent from passage 10 through to 30. For ease of description
the cell lines will be referred to using the abbreviations outlined in Table 1.
Abbreviation Cell line
NKIM2 Normal KIM2 cell line
Grown at 37°C in maintenance medium only
NKIM2-diff Normal KIM2 cell line stimulated to show mammary
differentiation in terms ofmilk protein production.
Derived by growing NK1M2 cells 2 days at confluency in
maintenance medium, and then exposing cells to differentiation
medium containing lactogenic hormones (at 37°C)
TKIM2 Transformed K1M2 cell line
Grown at 33°C in maintenance medium only
Table 1 Cell line Abbreviations and Terminology
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1.1 Morphology on phase microscopy
Confluent NKIM2 showed a cobblestone epithelial morphology whereas
TKIM2 were spindle-shaped and showed overlapping of cells. Figure 1.1 illustrates the
morphological differences between the two cell lines. The TKIM2 cells are pictured
semi-confluent and at a higher magnification than NKIM2, because the TKIM2 cells
were multilayered when fully confluent and therefore poorly resolved by phase
microscopy. A formal comparison of the growth kinetics ofNKIM2 and TKIM2 is
shown in section 2 (Transformation).
NKIM2 TKIM2
Figure 1.1 Morphological comparison of a, normal (NKIM2) (xlO) and
b, transformed KIM2 (TKIM2) (x25) by phase microscopy
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The morphology ofNKIM2-diff is illustrated in Figure 1.1.1, showing the presence of a
dome-like structure surrounded by a confluent monolayer. Each confluent T25 flask of
NKIM-2 diff cells contained approximately 10-20 domes of differing size and random
distribution. Analysis of 20 flasks showed that the mean time to develop domes after the
addition of differentiation medium was 12 days with a range of (10-14 days). Control
NKIM2 cells left in maintenance medium only for the same period did not form domes.
Examination of the dome-like structures in NKIM2-diff showed that many were
associated with cells with spindle-shaped, elongated cell processes, which were different
in appearance from the remaining epithelial cells. Two of these spindle cells are seen in
Figure 1.1.1 This raised the possibility that another cell type was present among the
NKIM2 cultures.
Figure 1.1.1 NKIM2-diffmorphology on phase microscopy (x 40)
The red arrow spans a dome-like structure and the black arrows identify
two cells with spindle-shaped cell processes
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a-actin and vimentin expression by immunofluorescence
In order to investigate the possibility of an additional cell type among KIM2 cells,
immunofluorescence experiments were performed using a-actin and vimentin, which
are recognised markers for myoepithelial and fibroblast cells respectively,
a-actin-positive cells were identified in NKIM2 at a low frequency (< 1%), after four
repeat immunofluorescence experiments. Figure 1.2 illustrates a-actin-positive cells
amongst the cobblestone NKIM2 monolayer. In order to generate the image, the green
immunofluorescent signal is superimposed on the phase microscopy background. In
addition, a computer-generated red background has been added to enhance the
appearance of the green immunofluorescent signal. The disappearance and reappearance
of the signal along the length of the cell processes suggested that the cell processes were
woven above and below the confluent monolayer.
Figure 1.2 a-actin-uositive myoepithelial cells in NKIM2 (x 40)
In contrast, no vimentin-positive cells were identified amongNKIM2 cells, in the
presence of a fibroblast positive control for the vimentin antibody. A negative result on
immunofluorescence consisted of a black field only, similar to the background seen in
Figure 1.2.2, and therefore will not be illustrated.
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Similar to NKIM2 cells, NKJM2-diff contained a-actin-positive cells at a frequency of
<1%, after 4 repeat experiments. Figure 1.2.1 a illustrates an a-actin-positive cell in
NKIM2-diff associated with a dome-like structure. Examination of this dome at
different focal planes revealed that all the other spindle- shaped cell processes seen in
the background are also a-actin-positive. Figure 1.2.1 b demonstrates that a
neighbouring cell process shows a clear green immunofluorescent signal in a different
focal plane.
a b
Figure 1.2.1 a, a- actin-positive myoepithelial cell in NKlM2-diff (x 40) b, different
focal plane on the dome. The grey arrows indicate background spindle-shaped cells
which immunofluoresce in different focal planes.
There was no evidence ofvimentin-positive cells among NKIM2-diff on repeat
immunofluorescence, in the presence of a positive control for the vimentin antibody.
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a-actin-positive cells were present at a very low frequency in TKIM2 cells (< 0.1%)
compared with NKIM2 and NKJM2-diff cells. Figure 1.2.2 a illustrates the only a actin
positive cell identified among TKIM2 cells after four repeat experiments, superimposed
on the phase microscopy background, and b illustrates the corresponding raw data signal
on a black negative background.
Figure 1.2.2 a-actin expression in TK1M2 cells (x40) a, superimposed on phase
microscopy background, b, raw data
The TKIM2 cells were vimentin-negative after experiments with positive controls,
similar to the NKIM2 and NKIM2-difF cells. A summary of the a-actin and vimentin
expression data is presented in Table 1.2.3. There was no significant difference in the
a-actin staining between theNKIM2, NKIM2-diff and TKIM2 lines.
Cell line a-actin (myoepithelial marker) vimentin (fibroblast marker)
NKIM2 9 cells per 1000 positive (< 1%) vimentin-negative
NKIM2-diff 9 cells per 1000 positive (<1%) vimentin-negative
TKIM2 1 cell per 1000 positive (<0.1%) vimentin-negative
Table 1.2.3 a-actin and vimentin expression in cell lines
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1.3 Serum starvation ofNKIM2
In order to assess the growth kinetics ofNKIM2 cells in response to serum deprivation,
a recognised protocol was followed [69].NKIM2 cells were seeded at the same density
(lx 105 cells) in maintenance medium for 24 hours, then washed with serum-free medium
before being seeded in either control maintenance medium (containing 10% fetal calf
serum) or maintenance medium with 0% serum. At 24 hour intervals culture plates within
each series were harvested and the cells counted, and medium replaced in remaining
plates. Figure 1.3 illustrates the growth curves (mean and standard deviation) ofNKIM2
cells from three independent experiments. It can be seen that after 5 days of serum
starvation the majority ofNKIM2 cells appear to die with only ~lxl02 cells surviving,
whereas control NKIM2 cells continued to proliferate. However this assay did not assess














Figure 1.3 showing the growth curve (mean and standard deviation from 3
experiments) ofNKIM2 cells after serum starvation, lx 105 cells were plated at
Day 0 and after 5 days, ~ lxlO2 cells survive
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Myoepithelial cells are thought to be resistant to stress than epithelial cells [95],
therefore immunofluorescence for a-actin was performed on the NKIM2 cells
remaining after 5 days serum starvation. Figure 1.3.1 illustrates two a-actin-positive
myoepithelial cells seen among surviving NKIM2 cells. Above the myoepithelial
cells a rounded cell is seen which is either in the process of dividing or dying.
Figure 1.3.1 Serum starvation ofNKIM2 for 5 days and a-actin
immunofluorescence of surviving cells. (x40)
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Electron microscopy of myoepithelial cells
Electron microscopy of the NKIM2 cells allowed identification of the a-actin-positive
cells as myoepithelial, due to the presence of characteristic myofilaments.
Examination of 100 fields ofNKIM2 cells confirmed < 1% of cells were myoepithelial,
corresponding to the proportion detected on the immunofluorescence data. Figure 1.4
illustrates a myoepithelial cell at lower power with the characteristic myofilaments
highlighted with a red arrow.
Figure 1.4 Morphology of a myoepithelial cell identified among NKIM2
cells on electron microscopy (neg.mag x6750, print mag.xl3500). The red
arrow highlights an area ofcytoplasmic filaments which is depicted at
higher power in 1.4.1
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Figure 1.4.1 illustrates the myofilaments at higher power, showing the characteristic
electron densities along their length which are indicative of actin-myosin assemblies at a
molecular level.
Figure 1.4.1 Higher power view ofmyofilaments (neg. mag. xl9799, print mag.
x39598). The red arrows indicate the characteristic electron densities along their
length
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Epithelial marker expression : E-cadherin and ZO-1
E-cadherin and ZO-1 are recognised markers for adherens and tight junctions
respectively, which are unique to epithelia [153].
E-cadherin was identified at areas of cell-cell contact in NKIM2 in both pre-
confluent and confluent cells, on four repeat experiments. Figure 1.5 a,b
illustrates E-cadherin expression occurring before NKIM2 cells reach
confluency, at individual cell borders. Growing cells were assessed for E-
cadherin localisation every 12 hours in order to determine when best to assess the
lines for this marker, and the earliest expression of E-cadherin was identified at
48 hours after splittingNKIM2 cells. Although in general expression was
identified at areas of cell contact, occasional cells lacking cell contact expressed
E-cadherin at their cell borders, as illustrated in Figure 1.5 b.
One possible explanation identified on time-lapse video microscopy of growing
KIM2 cells, is that cells form and lose temporary attachments during growth
before they reach confluence. Therefore the lone cell that expresses E-cadherin at
its borders may have recently lost contact with neighbouring cells.
Figure 1.5 a, Phase contrast image and b, E-cadherin expression in growing
NKIM2 cells (x40) The white arrow indicates E-cadherin expression at the
boundaries of a cells without contact with neighbouring cells
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Figure 1.5.1 illustrates the immunofluorescent E-cadherin signal between all NKIM2 cell
boundaries in a confluent culture, highlighting the cobblestone arrangement of cells.
a b
Figure 1.5.1 a, Phase contrast image and b, E-cadherin expression in NK1M2 cells (x25)
Examination of confluent NKIM2-difF cells similarly confirmed E-cadherin expression at
cell boundaries. Figure 1.5.2 illustrates E-cadherin expression in NKIM2-diff cells with a
dome-like structure surrounded by a flat monolayer. Study of the dome in different focal
planes confirmed that the immunofluorescence signal was continuous between cells on the
monolayer and the dome.
Figure 1.5.2 a, Phase microscopy image and b, E-cadherin expression in
NKIM2-diff cells (x25). The red arrow spans the dome-like structure.
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The ZO-1 expression pattern on repeat immunofluorescence, was identical in
appearance to the E-cadherin expression in both growing and confluent NKIM2 cells
and is summarised in Table 1.5.3 below. Figure 1.5.3 demonstrates ZO-1 expression in
NKIM2-diff cells at the boundaries between cells in a flat monolayer surrounding a
dome structure. When viewed in different focal planes, ZO-1 expression is continuous
between all cells forming the dome, similar to E-cadherin.
a b
Figure 1.5.3 a Phase contrast image and, b ZO-1 expression in NKIM2-diff cells (x
40)
Epithelial marker expression in theNKIM2 cells is summarised in Table 1.5.3.
Cell line E-cadherin ZO-1
Growing
NKIM2
expression occurs after cells meet
approximately 48 hours after
splitting cells
expression occurs after cells




present between all cell boundaries present between all cell
boundaries
NKIM2-diff present between all cells including
dome structures
present between all cells
including dome structures
Table 1.5.3 Epithelial marker expression in NKIM2
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Electron microscopy of tight and adherens junctions in NK1M2 cells
Both tight and adherens junctions were confirmed in NKIM2 cells by electron
microscopy. The presence of tight junctions correlated with the ZO-1 expression
seen by immunofluorescence. Figure 1.6 illustrates a tight junction between two
NKIM2 cells, which is denoted by the red arrow. The junction is the electron dense
area situated apically, where the outer leaflets of the apposing cell membranes are fused
becoming a single leaflet. The cell coat or glycocalyx is characteristically absent in this
area. Also present are apically arranged microvilli forming a continuous surface from
one cell to the next, which is the defining feature of polarised cells on electron
microscopy.
Figure 1.6 Electron microscopy demonstrating a tight junction (red arrow)
between two neighbouring NKIM2 epithelial cells (neg. mag. x 6750, print mag. x
13500). On the apical surface, microvilli are seen forming a continuous layer
between cells.
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The identification of adherens junctions between NKIM2 cells correlated with E-
cadherin expression seen by immunofluorescence.The adherens junctions identified
were either intermediate junctions or desmosomes. Intermediate junctions were
identified as areas between cells where the intercellular space was larger than normal
(about 200 Angstroms (A)) filled with medium electron-dense amorphous material, and
the adjacent cytoplasm was filled with minute filaments.
The desmosome or hemidesmosome were identified as button-like structures with an
intercellular space of about 250 A, also filled with electron-dense material. However in
contrast to the intermediate junction,
Figure 1.6.1 Two desmosomes between NKIM2 cells on electron microscopy (neg.
mag. x 41580, print mag. x 83160)
the paradesmosomal cytoplasm contained plate-like structures to offer anchorage for
cytoplasmic filaments. Figure 1.6.1 illustrates two desmosomes between two NKIM2
cells, denoted by the red pointers. The border between the two cells is not continuous
because it has been disrupted during preparation of the block for electron microscopy.
70
Interdigitation ofNKIM2 cells
As well as identifying tight and adherens junctions, an additional feature was identified
on electron microscopy between NKIM2 cells which is known as interdigitation, ie the
cytoplasm of both cells was very closely apposed in finger-like projections to increase
the surface area for communication between the cells. Figure 1.6.2 illustrates
interdigitation between the cytoplasm of neighbouring NKIM2 cells.
Figure 1.6.2 Neighbouring NKIM2 cells show interdigitation of their
cytoplasm on electron microscopy (neg.mag. xl0368, print mag. x20736)
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1.7 Polarisation
Examination ofNKIM2 cells by electron microscopy demonstrated apically arranged
microvilli which formed a continuous surface between neighbouring cells, thus
confirming cells were polarised. This is demonstrated at low power in Figure 1.7
where the microvilli are continuous between the central cells. The remaining peripheral
edges of cells in the figure do not show this feature because their relation to one another
has been disrupted during the cell-block preparation process. The continuity ofmicrovilli
between cells at higher power was illustrated previously in Figure 1.6 which also
illustrated tight junctions between NKJM2 cells.
Figure 1.7 Polarisation ofNKIM2 cells demonstrated by the presence
of apical microvilli running continuously between the centrally placed
cells (neg.mag. x2777, print mag. x5554)
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1.8 Milk protein expression
The potential for mammary differentiation in NKIM2 cells was assessed in terms of the
milk protein p-casein production, in response to the lactogenic hormones present in
differentiation medium. Figure 1.8 illustrates the immunofluorescent staining pattern
of the polyclonal P-casein antibody on a control histological section of late lactation /early
involution mammary gland. Although the P-casein antibody stains alveoli and milk-filled
ducts, there appears to be some non-specific staining on fat cells and vessels, which may be
due to cross reactivity of the antibody or milk protein present on these cells.
Figure 1.8 p- casein immunofluorescence in a histological section of control mammary
gland (x 10) Apart from staining alveoli, some staining of fat cells is seen
Despite this reservation regarding the P-casein antibody, immunofluorescence experiments
were carried out because the cell lines did not contain fat cells. NKIM2 cells had very
low levels of P- casein expression on four repeat experiments, whereas NKIM2-diff had high
levels of expression.
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Figure 1.8.1 illustrates the difference in p-casein expression by immunofluorescence
NKIM2 cells compared to NKIM2-diff cells. The undifferentiated NKIM2 cells in
Figure 1.8.1 a,b show low level cytoplasmic speckling, whereas differentiated
NKIM2-diff cells in c,d have strong cytoplasmic staining. Moreover, it is clear that
P-casein expression does not occur simultaneously in every NKIM2-diff cell.
c d
Figure 1.8.1 Comparison of P-casein expression in a,b NKIM2 cells
and c,d NKIM2-diff cells (x 40)
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Further study ofNKIM2-diff cells at different focal planes,
identified that p-casein expression was randomly distributed between the dome-like
structures and the monolayer. Figure 1.8.2 a,b. illustrates cytoplasmic P-casein expression
adjacent to a dome-like structure.
a b
Figure 1.8.2 p-casein expression in NKlM2-difT cells (x25). a, phase
microscopy image, b, immunofluorescence The red arrow indicates the
corner of a dome-like structure
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Western analysis of P-casein expression
In order to confirm the observations obtained by immunofluorescence, P-casein protein levels
determined by repeat Western analysis. Samples of equal protein concentration were loaded
into each lane. Figure 1.9 shows that protein levels are very low in NKIM2 cells and high in
NKIM2-diff cells. Unexpectedly,TKIM2 cells in maintenance medium alone also show P-
casein expression, but at a lower level than NKIM2-diff cells. Lactating mammary gland was
used as a positive control and the molecular weights in kilodaltons of protein markers are
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Figure 1.9 Western analysis comparing p-casein protein production in
NKIM2 cells, NKIM2-diff cells and TKIM2 cells
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1.10 Electron microscopy ofmilk production in NKIM2-diff
Electron microscopy ofNKIM2-diff cells to identify milk components lipid and protein
(caseins), correlating with the P-casein expression seen on immunofluorescence data.
The remaining components ofmilk ie sugar (lactose) and mineral salts are not readily
identifiable on electron microscopy. Figure 1.10 illustrates NKIM2-diff cells which
contain large numbers of lipid droplets varying in size. The smaller black electron dense
elements represent protein.
Figure 1.10 Milk production in cytoplasm ofNKIM2-diff cells on
electron microscopy (neg.mag. x 2777, print mag. x5554). The arrows
indicate cytoplasmic lipid vacuoles.
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Further examination ofNKIM2-diff cells revealed that only small numbers of protein
elements were identified in comparison to lipid vacuoles. Figure 1.10.1 illustrates the
lipid vacuoles in NKIM2 cells at higher magnification, with some fragmentation of their
contents caused by the preparation process. One dense black protein particle is visible.
Figure 1.10.1 Cytoplasmic lipid in NKIM2-diff cells on electron
microscopy (neg.mag. x 10368, print mag. x 20736). The red arrow
denotes a protein particle
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Figure 1.10.2 illustrates a protein particle at higher magnification which is composed
ofminute globules, each 25 A in diameter arranged in a crystalline array. This structure
is known as a protein micelle, which help transport ions in milk in vivo. A neighbouring
lipid vacuole is also present.
Figure 1.10.2 Protein micelle and lipid vacuole on electron microscopy ofNKIM-diff
cells (neg. mag. x 68040, print mag. x 136080)
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1.11 Discussion
A considerable body of data already exists as to the relevance of epithelial characteristics
and mammary differentiation in model cell lines, and the data presented on NKIM2 cells
conform with some of these findings.
In particular the morphological data (Figure 1.1) at a phase microscopy and electron
microscopic level are characteristic of epithelia [87, 88]. The overall epithelial
morphology ofNKIM2 is supported by the presence of epithelial markers E-cadherin
and ZO-1. E-cadherin is a traditional marker of epithelia, and has specific relevance to
suppression of transformation through adherens junctions [154] and therefore was chosen
over alternative markers such as keratins [157]. The data show that E-cadherin is expressed
when NK1M2 cells meet during growth, and this expression persists in confluent
NKIM2 cells and NKIM2-diff cells (Figure 1.5.1 and 1.5.2). This E-cadherin
expression in NK1M2 cells is consistent with previous studies in classic epithelial cell
lines such as the MDCK line [154]. Although dome-like structures are a unique
feature to theNKIM2-diff cells, MDCK cells form cyst-like structures in collagen which
similarly show E-cadherin expression [302],
The presence of the ZO-1 marker is not always assessed in classic epithelial cell lines,
although the tight junction is thought to be present in most epithelia together with adherens
junctions, [152], However it is relevant in mammary cells where the tight junction plays a
specialised function in pregnancy [300], In vivo, the tight junction impedes the passage of
small molecular weight substances between epithelial cells [301], but during pregnancy
before full lactation, tight junctions become leaky and allow components of the interstitial
space, such as inflammatory cells to enter the milk [300].
The expression of ZO-1 among NKIM2 cells (Table 1.) showed a similar distribution to
E-cadherin on immunofluorescence in NKIM2 cells. However there was no loss of ZO-1
immunofluorescence in NKIM2-diff cells (Figure 1.5.3) to parallel the in vivo leakiness
of tight junctions during pregnancy [156].
In order to further support the evidence regarding the epithelial nature ofNKIM2 cells,
both adherens (Figure 1.6.1) and tight junctions (Figure 1.6) were identified between
NKIM2 cells on electron microscopy. Although conventional transmission electron
microscopy provides a high level of structural detail, the monolayer is disturbed- because
preparation of the block involves spinning cells to form a pellet and consequently not all
cells remain attached or orientated to each other [299],
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An alternative method to preserve the monolayer when using transmision electron
microscopy, involves growing cells on specially designed coverslips in a glass bottomed
microwell. After dehydration and infiltration with resin, the coverslips are removed leaving
cells embedded in the resin and ready for further processing, with the monolayer intact [151].
Unexpectedly, electron microscopy also identified interdigitation between the cytoplasm of
certain neighbouring NKIM2 cells (Figure 1.7.1). Although this has previously been
described in cell types which require large surface areas for cell/cell communication,
such as renal tubular epithelial cells [299], it has not been observed previously in
equivalent mammary cell lines such as the HC11 or COMMA D lines. It is possible that
the combination of interdigitation, adherens and tight junctions contributed to NKIM2
remaining attached during the preparation process and allowed the assessment of
polarisation by electron microscopy.The polarisation ofNK1M2 lines was defined by the
presence of a continous apical microvilli layer between cells (Figurel .7) [302]. Apart from
being an epithelial feature, it is key for mammary function, in terms of milk secretion [303],
In vivo, polarised mammary epithelial cells transport proteins to apical or basolateral
surfaces [302]. An alternative method to determine polarisation of cells is to identify
Na/K/ATPase channels by immunofluorescence [267], which are only present on the
baso-lateral surfaces of polarised cells.
While the data discussed so far supports the epithelial nature ofNKIM2, the identification
of small numbers ofmyoepithelial cells among the NKIM2 cells via a-actin (Figure 1.2 ),
does introduce a small variable, particularly with reference to the proposed gene
transduction and analysis of the cell line. Classic epithelial cell lines such as the
MDCK line are pure epithelial, however the close association between epithelial and
myoepithelial cells, as well as the extracellular matrix in the mammary setting is well
recognised [95]. Although myoepithelial cells have not been described among the
frequently- used HC11 or COMMA D mammary cell lines, there are rat mammary cell
lines in use which are morphologically intermediate between mammary epithelial and
myoepithelial cell lines [294], The inclusion of the myoepithelial cell inNKIM2 may
have occurred during isolation of the NKIM2 cell line, however, two alternative
possibilities may explain the appearance of the specialised cell types within mammary
cultures. One is the presence of a mammary stem cell population within the cells which
retains the ability to differentiate into different cell types [295, 296], However this
remains contraversial partly due to the lack of intermediate lineage-specific markers to
follow cell differentiation [293],
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The second less likely explanation is that in rare situations mammary cells have a
degree of plasticity and can alter cell lineage in response to certain stimuli. [297],
This phenomenon- termed transdifferentiation, which is common during development,
is still poorly understood. It has been described very rarely in mammary epithelial cells,
one example being the transdifferentiation of cells in response to TGF-beta stimulation [297].
The a-actin immunofluorescence data also demonstrated that myoepithelial cells were
randomly arranged on the flat monolayer (Figure 1.2) in NKIM2, as well as being
associated with dome-like structures (Figure 1.2.2) among NKIM2-diff cells. In vivo
myoepithelial cells form a basket-like mesh around alveoli, and therefore it is tempting to
speculate that the myoepithelial cells in NKIM2-diff cultures are attempting to recapitulate
these structures in vitro. However three-dimensional cultures ofNKIM2-diff in Matrigel
would be necessary to examine this question in detail.
Although a-actin and other markers including cytokeratin and S-100 [293], are reliable
indicators ofmyepithelial cells, the recognition of the cytoplasmic myofilament
on electron microscopy provides definitive evidence of their presence (Figurel .4.1).
Studies have shown that myofilaments are composed of actin, tropomyosin and myosin
arranged in a similar pattern to smooth muscle, resulting in characteristic electron
densities [299].
Apart from the myoepithelial cell, fibroblast contamination of epithelial cultures is a
recognised problem during the development of epithelial cell lines, although this can
reduced by various separation techniques [84, 291, 292], However the lack of vimentin
expression on immunofluorescence (Table 1.2) and of fibroblast cells on electron
microscopy made it unlikely that these were present among NKIM2 cells.
While serum-dependence is not specific to epithelial cells and is more a feature of
•A
non-transformed cells, the data provides a baseline for experiments later sections.
The growth curve data demonstrate that the majority ofNKIM2 epithelial cells are
highly serum dependent (Figure 1.3.), and is in keeping with other epithelial cell lines [89],
In the mammary setting in vivo, it has been proposed that the death induced on withdrawal
of serum -which contains growth factors, may be analagous to the apoptotic removal
of the lobuloalveolar compartment in the mammary gland following weaning, when
there are great fluctuations in growth factor and hormone levels [94]. However although
there was a reduction in cell number in response to the serum deprivation experiments,
there was no formal measurement of death rates in the cells.
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The a-actin immunofluorescence data from the serum starvation experiments on
NKIM2 cells (Figure 1.3.1), show that certain myoepithelial cells survive starvation.
This may support a theory that the myoepithelial cell has a protective function in the
mammary gland in vivo and is more resistant to environmental stress [81 ]. However a
formal comparison of equal numbers of myoepithelial and epithelial cells would be
necessary to test this hypothesis.
A discussion ofmammary differentiation in NKIM2-diff cells revolves around the
response of cells to lactogenic hormones, particularly in terms of milk protein expression
[305]. The NKIM2-diff cells formed dome-like structures in response to lactogenic hormones
(Figure 1.1.1), and the significance of these structures is unclear. The formation of similar
'mammospheres' has been previously recognised in other mammary cultures grown on
basement membrane or Matrigel [287, 288]. It has been proposed that the mammospheres
show a resemblance to alveolar structures seen in pregnant and lactating mammary gland
in vivo [289], and that their formation occurs as part of a hierarchy of changes mediated
by the extracellular matrix [290], In the NKIM-diff cells, however, domes form in the
absence of extracellular matrix. One possibility is that the NK1M2 cells secrete laminin
a component of the basement membrane, allowing cells to form a dome structure which
is a forerunner of the mammosphere [94].Experiments growing NKIM2-diff cells in
three-dimensional cultures in Matrigel are necessary to explore this question further.
However the ability ofNKIM2-diff to secrete [3-casein in response to lactogenic hormones
(Figure 1.8.1) confirms that they exhibit mammary differentiation. This is analogous to
the HC11 mammary epithelial cell line which is similarly grown on plastic, and also
shows a rapid induction of endogenous [3-casein with the addition of lactogenic hormones
[88]. Although the polyclonal P-casein antibody used for both immunofluorescence and
Western analysis may have cross-reactivity with other cells such as adipocytes (Figure 1.8),
the likelihood of cross-reactivity was small because NKIM2 cells are comprised mainly
of epithelial cells.
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As expected, low levels of P-casein were present in NKIM2 cells on immunofluorescence,
compared with high levels in NKIM2-diff cells (Figure 1.8.1). Previous studies in cycling
virgin mice using in situ hybridisation, have shown that expression ofmilk protein genes
are identified within a few alveolar cells only [304], It may be that the low levels of
p-casein seen inNKIM2 cells, parallels this observation. In contrast, similar in situ
hybridisation studies in pregnant mice, show that milk protein gene expression increases
dramatically in a mosaic asynchronous manner, so that by early pregnancy (day 10),
P-casein is identified sporadically within pockets of alveolar cells throughout the gland
[166], InNKIM2- diff cells, high level P-casein expression was present only in a
proportion of cells, after 12 days in differentiation medium (Figure 1.8.1), perhaps
mirroring the mosaic asynchronous expression seen in vivo. However, P-casein-expressing
cells were distributed randomly, and not concentrated in dome-like structures in
NKIM2-diff cells (Figure 1.8.2). If the dome- like structures had paralleled the in vivo
alveoli, as previously suggested, one would expect the expression to be mainly in the
domes.
Several studies have identified p-casein expression as an early marker ofmammary
differentiation [305]. As pregnancy progresses, the expression of late differentiation
markers Whey Acidic Protein ( WAP ) and a-Lactoglobulin (a-Lac) are activated in a
mosaic fashion, in vivo [166]. However mammary epithelial cell lines are often unable
to express these late differentiation markers in vitro, and therefore they were not
assessed in NKIM2-diff cells.
Previous studies on P-casein have identified a difference in size between intracellular
P-casein (~29kDa) and the secreted protein (~32kDa), and have proposed that the
discrepancy may be due to differences in phosphorylation [305]. The p-casein identified
in our study was approximately 29 kDa (Figure 1.9) and is presumed to be the
intracellular protein. The other bands on identified on Western analysis have been
recognised previously with the same antibody and are thought to represent other caseins
[94] As expected, there was increased P-casein protein expression in NKIM2-diff cells
compared with NKIM2 cells (Figure 1.9), however the presence of p-casein among
TKIM2 cells was surprising and will be discussed.
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Both immunofluorescence and Western analysis data are supported by the detection of
the milk components lipid and protein, in NKIM2 diff cells on electron microscopy
(Figure 1.10). However, although abundant cytoplasmic lipid was identified, only scant
milk protein was present among NKIM2-diff cells which had been exposed to lactogenic
hormones for 12 days (Figure 1.10.). This contrasts with previous studies of lactating
mouse mammary gland which identified large amounts of milk protein using electron
microscopy [299]. Moreover (3-casein protein was readily identified on Western analysis
of equivalent NKIM2-diff cells (Figure 1.9). It is possible that the NKJM2-diff cells
studied by electron microscopy represented a small sample of cells with low milk protein
expression, similar to the non-staining NKIM2-diff cells present on immunofluorescence
for P-casein (Figure 1.8.1)
While most of the data presented aims to determine whether NKIM2 cells show epithelial
or mammary differentiation, a number of observations regarding TKIM2 were made.
Firstly, in transformed TKIM2, only one myoepithelial cell was identified by
immunofluorescence (Figure 1.2.1). The reason for the difference between the NKIM2
and TKIM2 cell line in terms of frequency of myoepithelial cells remains unclear,
although it may be that transformation in TKIM2 occurred in a clone of epithelial cells
which outgrew other cells. The data contrasts with a previous study which describes
differentiation of SV-40 transformed mammary epithelial stem-cell lines
to myoepithelial-like cells, in association with increased expression of SV40 virus large
T-antigen [298].
Secondly, the presence of P-casein protein in TKIM2 cells was unexpected, because it was
assumed that transformed cells would be less likely to express markers of differentiation.
It may be that in TKIM2 cells, innapropriate stimulation of pathways results in
endogenous p-casein expression. For example, studies have shown that one of the factors
(STAT5) which activates P-casein in normal cells, is upregulated in certain transformed
mammary cell lines [327], However expression of STATs was not explored in the TKIM2
cells.Thirdly, the general lack of vimentin and a-actin staining on immunofluorescence,
combined with p-casein expression on Western analysis (Figure 1.9) tend to indicate that
the transformed cells were originally epithelial rather than another cell type. Although in
general, it is difficult to identify the origin of cell lines once they are transformed,
particularly on morphological grounds alone.
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So in conclusion, to what extent do NKIM2 cells show both epithelial and mammary
differentiation? It is clear that both epithelial and mammary differentiation are
intertwined -previous studies have shown that cell-cell interactions promote mammary
epithelial cell differentiation [307], The NKIM2 cells satisfy a number of criteria for
epithelia in that they form appropriate junctions, express appropriate markers and are
polarised. One potential disadvantage is the presence of the specialised myoepithelial cell,
which may have different properties to the epithelial cell and would be difficult to
investigate separately, due to the small numbers present in the culture. However the
presence of both cell types is more representative of the in vivo situation.
In terms ofmammary differentiation, the NKIM2 cells express the milk protein p-casein
at high levels in response to lactogenic hormones. The relevance of the formation of
dome-like structures in response to lactogenic hormones is still unclear.
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2 Transformation
This section reports the data relating to the original cell lines before genetic manipulation,
in order to assess recognised features of transformation.
The experiments regarding in vitro growth kinetics plus and minus serum, growth in soft
agar, and p53 and T-antigen expression are carried out both at 37°C and 33°C




TK.IM2 consisted of spindle-shaped cells which showed multilayering ie no contact
inhibition, which have been shown previously (Figure 1.1). Further assessment of
TKIM2 by electron microscopy, revealed cells with irregular cell surfaces and gross
pleomorphism in terms of cell size and cellular organelles. Figure 2.1 illustrates a
representative field ofTKIM2 cells where there are large numbers of irregular
cytoplasmic projections and flaps, but no evidence of apical microvilli formation
as seen previously in NK.IM2 (Figure 1.6 and 1.7). Formal examination of 100 fields
under electron microscopy revealed no evidence of polarisation in terms of cell
orientation and apical microvilli formation [311],
Furthermore, no myoepithelial cells with cytoplasmic myofilaments were identified
in TKJM2 under electron microscopy, supporting previous data which found <0.001%
a-actin positive cells by immunofluorescence (Table 1.2). This was similarly assessed
by the examination of 100 fields under electron microscopy.
Figure 2.1 A representative field ofTKIM2 cells on electron microscopy
showing pleomorphism of cells, with no evidence of polarisation (neg.mag. xl963,
print mag.x3297)
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Electron microscopy to assess junctional formation
Further examination of TKIM2 cells, showed no evidence of junctional
specialisations, in 100 fields examined. Figure 2.2 illustrates a representative
field ofTKIM2 with two neighbouring cells lacking junction formation.
Figure 2.2 Representative field ofTKIM2 on electron microscopy
(neg.mag. x!963, print mag. x3297)
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Epithelial Marker Expression
The lack ofjunctions on electron microscopy corresponded with a lack of expression
of E-cadherin in TKIM2 cells at cell boundaries on immunofluorescence. Figure 2.3
illustrates the lack of organised E-cadherin expression seen in TKIM2 at a preconfluent
stage. When TKIM2 cells are confluent and cells overlap they similarly retain a diffuse
distribution, with no evidence of membrane localisation.
Occasional spots of bright autofluorescence seen adjacent to cells are caused by
cell debris. As expected, there was no evidence of ZO-1 expression in TKIM2 cells on
immunofluorescence, in the presence of a positive control. This appeared as a black
field with no signal and therefore is not illustrated.
a b
Figure 2.3 a Phase microscopy image, and b E-cadherin expression in









In vitro growth kinetics
In order to compare growth between cell lines, cells were counted according to a
recognised protocol [69], The TKIM2 and NKIM2 cells were seeded at the same
density (1 x 105 cells) in maintenance medium at 37° and 33°C. At 24 hour intervals
culture plates within each series were harvested and the cells counted. Figure 2.4
shows the growth curves drawn from three independent experiments. It can be seen
that TKIM2 cells appear to grow faster than NKIM2 regardless of temperature, but
there is a greater increase in cell number at 37°C compared with 33°C.
The greatest increase in cell number occurs between day 0 and 3 in all cell lines,
followed by a slower rate of increase between day 3 and 5. However the TKIM2
lines appear to increase in cell number faster than NKIM2 between day 0 and 3,
and it may be that NKIM2 lines show a degree of growth latency. This experiment
does not assay for apoptotic rates in individual cell lines, which may also contribute to
differences in cell number.
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Days
Figure 2.4 Comparison of growth curves (mean and standard




Previous studies have shown that transformed cells can survive in the absence of
serum [291 ]. From the previous chapter, it was observed that in conditions of
serum starvation, < 1% ofNKIM2 cells survive after 5 days ( Figure 1.3). In order to
investigate the growth kinetics of both lines without serum , they were
seeded at the same density (1 x 105 cells) at 33°C and 37°C in normal maintenance
medium for 24 hours, then washed and seeded in serum-free maintenance medium.
They were harvested and cells counted, similar to the previous experiment. Similarly no
measure of apoptosis was undertaken. Figure 2.5 illustrates the ability of TK1M2 cells
to grow in serum-free conditions compared to NKIM2 cells, ~ 97% of which died
after 5 days. The TKIM2 cells at 37°C increase in cell number at a faster rate than
TKIM2 cells at 33°C, as expected.
0 1 2 3 4 5
Days
Figure 2.5 Comparison ofgrowth curves (mean and standard
deviation from 3 experiments) ofTKIM2 and NKIM2 in serum-





To confirm that TKIM2 cells grow in serum-free conditions, Figure 2.5.1 illustrates the
growth ofTKIM2 cells after 1 day and 5 days in 0% serum. The cells at 5 days after
seeding show considerable multilayering, and it is difficult to identify individual
spindle-shaped cell bodies.
a b
Figure 2.5.1 Representative fields ofTKIM2 cells in 0% serum at a, 1 day and
b, 5 days after seeding at 37°C(xlO)
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Anchorage-dependence in Soft Agar
To assess anchorage-independent colony formation in soft agar, TKIM2 and
NKIM2 were seeded into soft agar at varying cell densities at 37°C and 33°C
according to a recognised protocol [220], as shown in Table 2.6. A colony was
defined as a spherical growth of cells over 5 mm in diameter. Positive
control Ras-transformed and negative control non-transformed cell lines
were supplied by D.B.
As expected, TKIM2 cells formed colonies at both 37°C and 33°C,
whereas NKIM2 did not form colonies at either temperature. TKIM2 cells
formed more colonies at 37°C compared with at 33°C, corresponding to
previous growth data.
Cells seeded TKIM2 at 37°C NKIM2 at 37°C
2xl04 12.6 +/- 1.5 0
lxlO4 11.0 +/-2.0 0
4xl03 9.2 +/-1.2 0
2xl03 8.4 +/-2.0 0
lxlO3 6.4 +/-1.7 0
TKIM2 at 33°C NKIM2 at 33°C
2xl04 9.0 +/-1.6 0
lxl 04 7.4 +/-3.0 0
4x103 7.0 +/- 1.4 0
2xl03 6.3 +/- 1.2 0
lxlO3 5.2 +/- 1.4 0
Table 2.6 Comparison ofColony formation in soft agar in TKIM2 and
NKIM2. Values are means and standard deviations from triplicated
experiments
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The difference between TKJM2 and NKIM2 in terms of colony formation in soft agar is
illustrated in Figure 2.6.1. The TKIM2 cells form large anchorage-independent






Figure 2.6.1 Growth in soft agar of a, TKIM2 and b, NKIM2 (x25) at 37°C
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Injection into scid mouse
Unexpectedly injection of the NK1M2 and TK1M2 cell lines in to scid mice
resulted in subcutaneous tumour formation in both lines at an overall identical take
rate of 25%, as illustrated in Table 2.7.
The size of the tumour harvested at 4 months did not significantly differ between
cell lines, although the mean tumour volume had not been compared during the
4 month period.
Cell line Incidence of tumours
(Take rate)
Size of tumours after
4 months
(Diameter in mm)
NKIM2 2/8 (25%) 32mm and 29mm
TKIM2 2/8 (25%) 30mm and 35mm
Table 2.7 Incidence of tumours in NKIM2 and TKIM2 cell lines
The histology of all tumours formed by both TKIM2 and NKIM2 lines was similar,
consisting of pleomorphic spindle-shaped cells, with few mitotic figures were visible,
as illustrated in Figure 2.7.1. By light microscopy alone, there was no evidence of
special tumour differentiation eg muscle striations, however immunohistochemistry
was not carried out to explore this further.
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Figure 2.7.1 Histology of tumours formed in scid mice of a, TKIM2 cells and b, NKIM2
cells. In b, tumour cells are penetrating subcutaneous muscle.
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p53 and T antigen expression
Immunofluorescence for p53 and T antigen resulted in strong nuclear staining in
NKIM2 cells (Figure 2.8) at 37°C and 33°C in passage 20 cells. T antigen is normally
found in the nucleus [93], however the presence p53 in the nucleus rather than the cytoplasm
suggested that T antigen was binding p53.
The positive control for p53 was the mammary HC11 cell line, which is immortalised by
mutant p53 and negative control was omission of the primary antibody. The positive control
for T antigen was SV40 T antigen-immortalised canine kidney epithelial cells donated by
C.S and the negative control was omission of the primary antibody.
Figure 2.8 Comparison of a, p53 and b, T antigen distribution in
representative fields ofNKIM2 cells at 37°C (p20) (x40)
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Similarly, immunofluorescence for p53 and T antigen resulted in nuclear staining
in TKIM2 cells (Figure 2.8.1) at 37°C and 33°C in passage 20 cells.
Figure 2.8.1 Comparison of a, p 53 and b, T antigen distribution
in representative fields ofTKIM2 cells at 33°C (p20) (x40)
Although the nuclear localisation of p53 and T antigen suggests that T antigen is
binding p53, the ideal method to prove that they are bound is to carry out an
immunoprecipitation analysis. This involves using beads to isolate molecules bound
to p53 antibody, and then probing this isolated sample with the T antigen antibody (or
verse) to confirm that the two are associated. However this methodology
did not work with the p53 and T antigen antibodies used in this study.
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2.9 Chromosome metaphase analysis
Chromosome analysis was undertaken to compare the karyotypes ofNKIM2 and TKIM2.
Previous DNA flow cytometry data on KIM2 cells predicted that the cells had an unstable
chromosome content at an early passage (p5), however that DNA content stabilised in mid
passages (p 15-p30)[318]. Therefore metaphase spreads were prepared at passage 20 in both
NKIM2 and TKIM2.
The control diploid rat embryo fibroblast cell line was provided by M.L., and contained
the expected 40 mouse chromosomes. However both NKIM2 and TKIM2 lines contained
a range of chromosome numbers with a median of 78 and 84 respectively, from a count of 20
metaphase spreads (Figure 2.9). There was no significant difference between chromosome
number between NKIM2 and TKIM2 at p20, although TKIM2 did contain a greater range
of chromosome counts
Figure 2.9 Chromosome number (median —■, and range) from 20













The numbers of chromosomes were so large in both NKIM2 and TKIM2, that it was
impossible to karyotype the mouse chromosome preparation either by computer
analysis packages, or using an experienced cytogeneticist (M.L). A representive
metaphase spread from NKIM2 and TKIM2 is illustrated in Figure 2.91 and 2.9.2




Figure 2.9.1 Representative metaphase spread from NKIM2 (p20)
» . fc' •'K „
&
Figure 2.9.2 Representative metaphase spread from TKIM2 (p20)
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2.10 FISH analysis of chromosome 11
FISH analysis with chromosome paint 11 was undertaken to compare chromosome 11 in
NKIM2 and TKIM2, which is the locus of p53 in the mouse.
Figure 2.10 illustrates the range of chromosome 11 found per cell in NKIM2 and TKIM2
with median values of 5 and 6 respectively in 20 metaphase spreads. This presumably
reflects the great range of total chromosome numbers found on metaphase analysis
(Figure 2.9). However there was no consistent loss of chromosome 11 in NKIM2 or TKIM2.
Counts were carried out similar to the previous experiment and as expected the control cell
line had 2 copies of chromosome 11 per cell (not shown).
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Figure 2.10 Comparison of number (median—, and range)
of Chromosome 11 in NKIM2 and TKIM2 cell lines (p20)
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Figure 2.10.1 illustrates FISH analyses of chromosome 11 in a, NKIM2 and b,
TKIM2. Both show five chromosome 11 per cell, however the break seen in the
green signal of one chromosome in 2.10.1 a is due to an overlying chromosome
blocking view of the signal, determined by computer-assisted analysis.
Figure 2.10.1 FISH analysis of chromosome 11 in a, NKIM2 and b, TKIM2. The
break in the green signal in a, is due to an overlying chromosome.
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Figure 2.11 Comparison of the number (median —■, and range)
of Chromosome 17 in NKIM2 and TKIM2 (p20)
A similar analysis was carried out on chromome 17, the murine locus of SEN 6 which is
thought to underlie immortalization in SV40 immortalised human fibroblasts [134], This
revealed similarly no consistent loss of chromosome 17 in NKIM2 and TKIM2 cells, and a
range of values per cell. Figure 2.11 illustrates a comparison of chromosome number 17
in 20 cells, with a median of 4 and 3 in NKIM2 and TK.IM2 cells respectively. Similar
counts and controls were used as in the FISH analysis of chromosome 11.
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Figure 2.11.1 illustrates FISH analysis of chromosome 17 in a, NKIM2 and b,
TKIM2 cells. TheNKIM2 cell contains four chromosome 17 and the TKIM2 cell
contains two chromosome 17.
Figure 2.11.1 FISH analysis of chromosome 17 in a, NKIM2 and b,
TKIM2
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Table 2.11.2 Summarising Features ofTKIM2 compared to NKIM2
NKIM2 TK1M2
Morphology Epithelial Spindle
=)ome formation Present Absent
function formation Present Absent
Epithelial marker expression At cell-cell junctions Cytoplasmic
(n vitro growth kinetics Steady growth Rapid proliferation
Serum-dependence Present Absent
Anchorage-dependence Present Absent
Tumour formation in scid
mice
2/8 (25%) 2/8 (25%)
lp53,T antigen expression Nuclear expression Nuclear expression
Metaphase spreads Median 78 (range 40-88) Median 84 (range 42-108)
Chromosome 11 Median 5 (range 2-8) Median 6 (range 3-11)
Chromosome 17 Median 4 (range 3-6) Median 3 (range 2-8)
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Discussion
The biological features used to define transformation are derived from an impressive
amount of data on transformed lines, and in general the TKIM2 cells fulfil these criteria.
In particular the spindle-shaped morphology and lack of contact inhibition
of TKIM2 cells (Figure 1.1) are features shared by transformed lines in general,
as well as equivalent SV40 transformed cell lines [143, 308], Similarly, previous studies
have observed that the surface of transformed cells is more irregular than
normal, with a relative increase in surface microvilli and cytoplasmic flaps, and a loss
of microvillous polarity on electron microscopy, as seen in TKIM2 cells (Figure 2.1)
[144, 309, 310]. Although the ultrastructure of individual organelles has been extensively
compared in normal versus transformed cells [139], it is rather the cumulative differences
in terms of overall pleomorphism and varying organelle numbers which is thought to be
significant. Moreover previous studies indicate that differences in cell surface and
intercellular junctions appear more reliable markers of transformation [150],
The lack of junctional specialisations in TKIM2 on electron microscopy (Figure 2.2) is
consistent with previous literature which describes either absent or a reduced number of
poorly formed, junctions in transformed cell lines [155]. The lack of E-cadherin expression
at cell-cell boundaries in TKIM2 cells on immunofluorescence (Figure 2.3) concurs with
this data. However, a previous study examining E-cadherin expression in human carcinoma
cell lines, suggests that epithelioid carcinoma lines (eg MCF7) generally express E-cadherin
at cell boundaries, whereas spindle-shaped, fibroblastoid, cell lines (eg MDA-MB45s)
completely lack E-cadherin expression [212]. Other studies suggest that it is a loss of
E-cadherin function as opposed to expression, that is significant in the fibroblastoid cell
lines [211]. It is likely that any E-cadherin protein detected in the TKIM2 cells in this study,
is not playing a functional role in terms of cell-cell adhesion.
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Apart from morphology and lack ofjunctions, certain accepted features of transformed
cells stem from their lack of growth control [312, 313].
The overall lack of growth control in TKIM2 was illustrated by the growth kinetics
experiments showing that TKIM2 proliferated more rapidly than control NKIM2 cells
at both growth temperatures (Figure 2.4). Supporting this evidence was the ability of
TKIM2 cells to proliferate when lacking serum (Figure 2.5). Transformed cells are
serum-independent because they produce inappropriate amounts of the growth factors
found in serum which normally regulate growth [173].
While anchorage-independence of transformed cells is thought to result from abnormal
function of integrin-mediated pathways, certain studies have proposed a link between
these and growth-control pathways. In particular SV40 large T antigen is thought to affect
both growth and integrin-mediated pathways, and previous studies have demonstrated that
SV40-transformed cells show both serum and anchorage-independent growth [177].
Therefore ability ofTKIM2 cells to form anchorage-independent colonies in soft agar
(Figure 2.6), and grow without serum (Figure 2.5) is consistent with previous studies.
In principle, the tumour formation in scid mice of injected TKIM2 cells, supports
the theory that TKIM2 are transformed (Figure 2.7.1). However, previous studies have
suggested that SV40 T antigen alone will not make cells tumorigenic, but that an additional
event such as overexpression of the Ras oncogene is also required [119], It is possible that
a random additional event in the TKIM2 analysed may have occurred, as indicated by the
great variation in chromosome number in the line. However the formation of tumours by
NKIM2 cells at the same take rate of 25% (Table 2.7) as TKIM2 cells, was unexpected and
difficult to explain. Conventionally non-transformed cells should not have the capacity to
form tumours in scid mice. However 'immortalized' non-transformed lines sometimes
prove an exception to this rule, for example the HC11 mammary epithelial cell line,
which is immortalized by mutant p53, also appears to be tumourigenic in mice [88].
It is possible that the immortalization strategy of SV40 T antigen in both NKIM2 and
TKIM2 promoted tumourigenesis, however this means that further results from scid mice
experiments in manipulated lines should be interpreted with caution.
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Further to this, the overall take tumour take rate in the scid mice experiments appears low.
The experiments utilised Matrigel, which is a solubilised tissue basement membrane
extracted from the Engelbrowth-Holm Swarm (E.H.S.) mouse tumor, which acts as a
biologically active matrix material [187], Coinjection of the cell suspension with Matrigel
is known to improve the efficiency of xenografting, particularly in mammary lines [187],
Oestrogen pellet supplementation is also used to improve tumour take rates
in certain mammary lines , however it has varying efficiency and in rare cases actually
inhibits the growth lines, and therefore was not used in this study [187],
The histology of all tumours assessed by light microscopy in NK1M2 and TKIM2
lines appeared similar, although full investigation of tumour differentiation would require
further immunohistochemistry. The spindle 'sarcoma-like' appearance of tumours
caused by SV40 large T antigen has been described previously, in addition to other
SV40 large T antigen induced phenotypes [142], However analysis of each tumour for
T antigen would be required to ensure that it was involved in formation of the lesions
identified.
The data confirms that both p53 and T antigen both localise to the nucleus in NKIM2 and
TKIM2 (Figure 2.8 and 2.8.1), suggesting that they are binding to each other. Further
confirmation that p53 was in the nucleus could have been achieved by counterstaining
the p53- expressing cells with a DNA stain such as DAPI (4',6-diamidino-2-phenylindole),
which highlights the nucleus only. Previous studies have shown that cellular wild-type p53
is normally regulated by rapid turnover and the level present in the nuclei of normal cells is
below the sensitivity of immunohistochemical detection [123]. It is also known that SV40
large T antigen complexes wild-type p53 protein and inactivates its transcriptional activity
[315], This may be one explanation for the appearance of p53 in the cell nuclei in NKIM2
and TKIM2, although another would be mutation of endogenous p53 in the cell lines.
An ideal experiment would be to probe cell lines with T antigen and p53 antibodies by
immunoprecipitation analysis, to see if both were complexed to each other.
An alternative way to assess whether T antigen was binding p53 and abrogating its
activity, would be to assess p21WAF1/CIP1. p21 is downstream of functional p53,
and is strongly upregulated after DNA damage eg ionizing radiation [316],
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Previous studies have shown only very weak accumulation of p21 in human breast
adenocarcinoma cell lines which have p53 inactivated by SV40 large T antigen, after
ionizing radiation, [316, 317]. The presence and activity of pRb, the other main factor
which SV40 T antigen binds, was not assessed in this study.
It has been previously suggested that SV40 virus immortalization or transformation may
occur secondary due to chromosome instability, caused by the abrogation of p53 function
by T antigen [122]. Chromosomal analysis ofmetaphase spreads, showed that both NKIM2
and TKIM2 had a large and variable chromosome number per cell. The median number of
chromosomes per cell for NKIM2 was 78 (range 40-96 ) and for TKIM2 was 84
(range 46-98) (Figure 2.9) at passage 20, while the chromosome number for control
diploid cells was 40. One way of assessing chromosomal content with increasing passage
number would be to use DNA flow cytometry analysis. Previous analysis ofNKIM2 using
this method has shown initial instability at passage 5 with loss of chromosomal content with
each passage, and subsequent stabilisation of content at passage 20 [318], TKIM2 cells have
not been analysed using this method.
It was not possible to identify chromosomes by karyotype analysis of cells, due to the large
and variable chromosome number in KIM2 cells. Therefore FISH analysis was used to
investigate whether there was chromosome loss of known senescent or tumour-suppressing
loci namely: chromosome 11 - the locus of p53 and chromosome 17- the locus of SEN 6.
FISH analysis demonstrated a large variation in the number of chromosome 11 present in
each cell, presumably reflecting the overall chromosomal variability (Figure 2.10). There
was no evidence of a consistent loss of chromosome 11 inNKIM2 cells or TKIM2 cells,
suggesting that endogenous or acquired disruption of the p53 locus was not responsible for
the immortalization and transformation in these cells. This evidence tends to support the
immunofluoresence data, which points to an abrogation of p53 function through SV40 T
antigen. However to determine definitively that the p53 locus is not altered in these cells,
further detailed experiments involving restriction fragment length polymorphism (RFLP),
more detailed FISH analysis and PCR would be required.
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Several similar previous studies have shown that in vivo human breast cancer is associated
with loss of heterozygosity of chromosome 17 p, where p53 gene is located in humans [319],
Moreover, the HC11 mammary epithelial cell line has a missense mutation in exon 5 and a
point mutation at the intron 4/ exon 5 junction at the locus of p53, leading to a splicing error
resulting in abnormal function of the p53 protein [89].
A potential candidate for chromosomal loss or mutation secondary to the action of SV40 T
antigen is chromosome 17- the locus of the mouse equivalent of SEN6.
FISH analysis of this locus in KIM2 cells showed a large variation in the number of
chromosome 17 per cell (Figure 2.11). Similar to the previous FISH analysis, there was no
evidence of consistent loss of chromosome 17 in NKIM2 or TKIM2 cells, and in order to
fully characterise the SEN6 locus in the KIM2 cells, a range of experiments would be
required. Previous studies in human lines, have shown that loss of chromosome 6q26-27
underlie SV40 mediated immortalization of human fibroblasts [134], In this model,
expression ofT antigen extends the lifespan of the fibroblasts only, but chromosome loss
of SEN 6 was required to immortalize them. However a key difference between the human
fibroblast model and the KIM2 model is that unlike murine cells, human fibroblasts almost
never immortalize spontaneously. Therefore, it may be that human cells have a more complex
hierarchy of controls that have to be breached in order for tumour formation [134],
So in conclusion, to what extent do TKIM2 cells show features of transformation?
The TK.IM2 cells fulfill all the criteria for a transformed cell line including lack ofjunctions
and contact inhibition; serum-independence; growth in soft-agar and tumour formation in
immunosupressed mice. In general the NKIM2 cells do not fulfil these criteria, and could be
considered non-transformed. However, the main evidence which does not fit this model, is
the tumour formation ofNKJM2 cells in scid mice.
Both T antigen and p53 localise to the nucleus in NKIM2 and TKIM2 cells,
and it is likely that T antigen is abrogating the function of p53, resulting in general
chromosomal variability, in both lines. Examination of the murine equivalent of p53 and
the SEN6 locus, showed no evidence for consistent loss in either NKIM2 or TKIM2 lines.
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3 Retrovirus
The data in this section refer to the retroviral transduction ofNKIM2 and TKIM2 cells with
Tiam 1 constructs, which was assessed by Western analysis. The Western analyses were
repeated on three occasions, using cells harvested from confluent T25 flasks, with equal
protein concentrations loaded in each lane. Standard protein markers were used to assess the
different sizes of the truncated control and active protein Tiaml constructs detected by the
Tiaml antibody.
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Endogenous levels of Tiaml in untransduced NKIM2 and TKIM2
Western analysis of endogenous levels of full length Tiaml in both untransduced
NKIM2 and TKIM2 identified practically zero levels of protein. Figure 3.1 illustrates
Western analysis in untransduced NKIM2 (passage 20) and TKIM2 (passage 6) showing
no bands at the expected size (~200kD). The positive control was neural tissue which is
known to express high levels of endogenous Tiaml and which is associated with numerous
breakdown products. It may be that the very faint lower bands represent breakdown
products of endogenous Tiaml in both NKIM2 cells and TKIM2 cells (R.K. personal
communication).











Figure 3.1 Western analysis of endogenous Tiaml in NKIM2 and TKIM2.
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Transduction of Tiam 1 into NKIM2 and TKIM2
The two retroviral constructs that were used to infect target NKIM2 and TKIM2 cells were
CI 199 Tiaml - the active construct with an expected size of 160 kilodaltons (kd), and C580
Tiaml- the control construct with an expected size of 81 kd (see Materials).
The constructs contained antibiotic-selection markers, so that cells that were not transduced
with the constructs did not survive when the G418 antibiotic was added to the
maintenance medium following transduction.
The efficiency of transduction was judged to be high (approximately 90% of cells survived
antibiotic selection). After transduction, the control and active Tiaml constructs appeared to
be strongly expressed in approximately equal amounts in all four transduced lines on Western
analyses. Figure 3.2 illustrates the Western analysis showing high Tiaml protein levels






Figure 3.2 Western analysis of retroviral Tiaml transduction
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Tiaml construct expression
Western analysis showed that transduced contructs were expressed for atleast 3
months following transduction. Figure 3.3 illustrates Western analysis repeated
after both NKIM2 ( passage 47) and TKIM2 cells (passage 40) had been
continuous culture for 3 months. Both CI 199 Tiaml and C580 Tiaml construct
expression remained present, however the levels of expression of the active














Figure 3.3 Western analysis of Tiaml expression after 3 months passaging
NKIM2 (p47) and TKIM2 (p40).
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3.4 Discussion
The data shows that endogenous levels ofTiaml in both NKIM2 and TKIM2 are
negligible (Figure 3.1), with the exception of possible faint breakdown products identified
on Western analysis. The lack of endogenous full length Tiaml in NKIM2 cells concurs
with previous studies of murine Tiaml expression, which have shown low or neglible
levels in most normal tissues, except brain and testis [245]. The low expression ofTiaml
in normal tissues may be a result of the instability of the protein, which is probably
mediated by the PEST domain in its structure [230], Moreover, at a functional level
guanine nucleotide exchange factor is required to continually exchange GDP to GTP on
Rac, and therefore it could be predicted that protein levels would be tightly regulated.
The low level of endogenous Tiaml in TKIM2 lines is not consistent with the majority of
transformed cell lines, which show in general show high Tiaml expression [245], In
particular the human HBL-100 mammary epithelial line immortalised by SV40 large
T antigen expresses Tiaml at high levels, as does murine breast carcinoma cell line
TA3 ST. However certain tumour or transformed lines have much lower levels of Tiaml
expression, for example the MCF7 cell line [245], In all the transformed cell lines
examined, the normal 7 kb Tiaml transcript was found without evidence for major
alternative splice events or truncation.
Retroviral transduction ofCI 199 and C580 Tiaml constructs resulted in strong and
approximately equal expression in all four cell populations (Figure 3.2). This concurs
with previous studies using the same CI 199 Tiaml and control C580 constructs in
phenotypic reversion ofRas-transformed epithelial MDCK cells [242].
Ideally as part of the retroviral transduction, a control empty retroviral vector should
have been transduced into the KIM2 cells, together with the Tiaml construct, but there
was not sufficient virus for this. However the identical vector had been used in the
Ras -MDCK study under the same conditions, showing that it was not responsible for the
biological effects observed [242].
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The data shows that Tiaml construct expression remained present during three months
passaging ie to passage 40 in NKIM2 cells and passage 47 in TKIM2 cells (Figure 3.3).
The experiments characterising phenotypic reversion in transduced cells, were therefore
carried out between passages 20-40 (Results chapter 4 ). One of the accepted features of
retroviral transduction is that the continued retroviral gene expression might drop over a
period of weeks to months depending on the cell line, site of integration, relative toxicity
of the insert [203, 209],
This may explain the slightly reduced expression of the active Tiaml construct at the end
of the three month period .However in general the expression of the Tiaml constructs
remained stable over an appropriate experimental period.
So, in conclusion untransduced NKIM2 and TKIM2 has very low levels of endogenous
Tiaml, and both lines were successfully transduced with active and control constructs.
The expression of these constructs remained present for atleast 3 months in cell culture.
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4 Phenotypic Reversion
This section contains data referring to the KIM2 cell lines after retroviral transduction
with active and control Tiaml constructs.
The Tiaml constructs comprise the CI 199 Tiaml construct which has a N-terminal
truncation and is active at areas of cell-cell contact [234], and a short C580 Tiaml
construct which is also N- terminally truncated, but has been shown in previous
studies to localise to the cytoplasm [234]. These will be referred to Tiam-active and
Tiaml-control respectively. Table 4 summarises the terminology used for the four
transduced cell lines.
Cell line terminology Description
NKIM2 plus
Tiaml-control












Transformed KIM2 cells transduced with active CI 199
Tiaml construct
Table 4 Terminology referring to the four transduced cell lines
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Morphology of transduced cell lines
As expected NKIM2 cells transduced with Tiaml -control constructs retained an
epithelial, cobblestone morphology (Figure 4.1 a). However although the majority of
NKIM2 cells transduced with Tiaml-active constructs remained epithelioid, certain cells
appeared rounded and showed ruffling of their membranes (Figure 4.1 b). A cells
showing membrane ruffling is identified by the red arrow.
The morphology of all transduced cells lines remained constant after intervals of
48 hours, 7 days and 14 days following transduction.
Figure 4.1 a,b Morphology ofNKIM2 cells transduced with
a, Tiaml-control and b, Tiaml-active (x25)
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TKIM2 cells transduced with Tiaml-control remained spindle- shaped with a lack of
contact inhibition, continuing to grow in multilayers (Figure 4.1.1 a), however TKIM2
cells transduced with Tiaml-active showed a remarkable change in phenotype, with cells
becoming rounded and gaining an epithelioid appearance Figure 4.1.1 b). They showed
contact inhibition ofmovement, with no evidence ofmultilayering. Flowever certain cells
showed ruffling of their membranes similar to NKIM2 cells in Figure 4.1 b.
Figure 4.1.1 Morphology ofTKIM2 cells transduced
with a, Tiaml-control and b, Tiaml-active. b, contains cells showing
membrane ruffling (4) (x 25)
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Dome formation
When all four cell lines were grown in differentiation medium for 12 days, only NKIM2
cells transduced with Tiaml-control formed domes, the remaining cell lines appeared
unchanged in morphology. Figure 4.1.2 illustrates dome formation in NKIM2 cells
transduced with Tiaml-control.
Figure 4.1.2 Dome Formation in NKIM2 cells transduced with control Tiaml
(xlO)
Presence ofmyoepithelial or vimentin marker expression
There was no evidence of a-actin or vimentin expression in any of the four cell lines on
repeated immunofluorescence experiments, in the presence of positive controls. The
black background seen in a negative result has been illustrated previously in Results
sectionl (Figure 1.2.2 b)and therefore will not be illustrated here.
Furthermore, no myoepithelial filaments were identified on electron microscopy in
all four cell lines.
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Epithelial marker expression E- cadherin
E-cadherin expression occurred in both NKIM2 cell lines transduced with
Tiaml-control and Tiaml-act. Figure 4.3 a,b illustrates a comparison ofE-cadherin
expression in both cell lines, showing that it is distributed between cell boundaries
in both. There appears to be an increase in E-cadherin expression in NKJM2 transduced
with Tiaml-active compared with NKIM2 transduced with Tiaml-active .
Figure 4.3 E-cadherin expression in NKIM2 cells transduced with a, Tiaml-control
and b Tiaml-active (x40)
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E-cadherin expression in TKIM2 cells transduced with Tiaml-control
showed a diffuse distribution whereas the reverted TK.IM2 cells
transduced with Tiaml-active, showed E-cadherin expression at certain, but not
all cell-cell boundaries. Figure 4.3.1 a,b illustrates a comparison ofE-cadherin
expression in both the TKIM2 lines.
Figure 4.3.1 Comparison ofE-cadherin expression by immunofluorescence in TKIM2
cells transduced with a Tiaml-control (x25) and b, Tiaml-active (x 40)
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In order to determine whether the differences in E-cadherin expression distribution
with change in morphology on immunofluorescence (Figure 4.3 a,b) was reflected
by changes in protein levels,Western analysis was carried out using equal protein
concentrations in each lane (Figure 4.3.2). This illustrated a large increase in levels ofE-
cadherin protein in NKIM2 cells transduced with Tiaml-active compared with Tiaml-
control. However the increase between TKIM2 transduced with Tiaml-active compared
with Tiaml-control was only slight. The positive control used was untransduced NKIM2
cells-which had high levels of E-cadherin confirmed by immunofluoresence. Therefore
TKIM2 cells transduced with Tiaml-active expressed protein at lower levels to the
control, whereas NKIM2 cells transduced with Tiaml-active expressed E-cadherin at
much higher levels.
Figure 4.3.2 Western analysis of E-cadherin levels in cell lines transduced by Tiaml
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ZO-1 expression was present in NKIM2 cells transduced with Tiaml-control and
Tiaml-active only, but not in either TKIM2 cell line. Figure 4.3.3 illustrates ZO-1
expression in NKIM2 cells transduced with Tiaml-control. The expression differed
from ZO-1 staining in untransduced cells in that it was not uniform at all cell-cell
boundaries.
a b
Figure 4.3.3 Phase microscopy and ZO-1 expression in NKIM2 cells transduced
with Tiaml-control
The epithelial marker expression in all four cell lines is summarised in Table 4.3.3





















Table 4.3.3 Summary of epithelial marker expression in transduced NK1M2 and
TKIM2 cell lines
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Electron microscopy of junctions
Both NK1M2 cells transduced with Tiam-control and Tiaml-active had an epithelial
appearance with microvilli on their apical surface. Figure 4.4 illustrates NKIM2 cells
transduced with Tiaml-control. The cells show no pleomorphism or irregular
features. Tight junctions are identified between certain cells.
Figure 4.4 Morphology ofNKIM2 cells transduced with Tiaml-control by
electron microscopy (neg mag x2100, print mag x3034)
The arrows denote tight junctions which can be observed between certain cells
at their apical margins
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An illustration of the junctions identified in untransduced NKIM2 cells is included
(Figure 4.4a) for direct comparison with junctions formed in NKIM2 cells transduced
by Tiam-control and Tiam-active on the following page.
Figure 4.4a Two desmosomes between NKIM2 cells on electron microscopy (neg.
mag. x 41580, print mag. x 83160) for comparison with Figure 4.4.1
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Electron microscopy ofjunctional formations at higher power show that junctions
are present in both NKIM2 transduced with Tiaml-control and Tiaml-active. The
majority ofjunctional specialisations were adherens junctions, however these did not
include desmosomes or hemidesmosomes, as due to the lack of electron dense
parajunctional cytoplasmic filaments. Figure 4.4.1 a,b illustrates junctions formed in
NKIM2 transduced with Tiaml-control and Tiaml-active respectively.
b
Figure 4.4.1 Junctional formations in NKIM2 cells transduced by a,
Tiaml-control and b,Tiaml-active (neg mag x 5780, print mag x 12000)
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The morphology ofTKIM2 cells transduced with Tiam-control showed pleomorphic
cells with irregular cell surfaces similar to untransduced TKIM2. Figure 4.42
illustrates the cells which have no junctions between cells, and no apical microvilli.
Figure 4.4.2 TKIM2 cells transduced with Tiaml- control by electron
microscopy (neg mag x 6640, print mag x 12600)
TKIM2 cells transduced with Tiaml-active had an unexpected irregular appearance
on electron microscopy (Figure 4.4.3). Although cells appeared more rounded than
TKIM2 cells transduced with Tiaml-control (above), they were still pleomorphic and
not polarised. Flowever, the red arrow denotes a junctional formation.
Figure 4.4. 3 TKIM2 cells transduced by Tiaml-active by electron microscopy
(neg mag x 5560 , print mag x 11200). A junctional formation is denoted by (4)
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Further examination of these occasional junctional specialisations at higher power,
showed that they were of adherens type, but not desmosomes or hemidesmosomes
because they lacked parajunctional densities. Tight junctions were not identified in
the reverted TKIM2 cells transduced with Tiam 1-active. Figure 4.4.4 illustrates a
junctional specialisation seen in reverted TKIM2 transduced with Tiaml-active.
Figure 4.4.4 Adherens junctional specialisation seen in TKIM2 cells
transduced with Tiaml-active (neg mag x 7075, print mag x 13500).
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4.5 Polarisation
Figure 4.4 and 4.4.2 illustrated the only two populations which had apical microvilli ie
showed polarisation on electron microscopy were NK.IM2 cells transduced with
Tiaml-control and NK.IM2 cells transduced with Tiaml-active.Both TKIM2 lines
transduced with Tiaml-active and Tiaml-control lacked apical microvilli (Figure 4.4.2 and
Figure 4.4.3)
4.6 Milk protein expression
p-casein protein production was identified in all transduced cell lines exposed to
differentiation medium, as immunoprecipitation analysis of all four transduced cell
lines illustrates (Figure 4.6). Although immunoprecipitation analysis allows clean specific
identification of the desired protein when using a polyclonal or less specific antibody, the
relative amounts of protein produced in each population is not assessed by this assay.
Lactating mammary gland was used as the positive control.
NKIM2 TKIM2
Control Tiaml Tiaml Tiaml Tiaml





Figure 4.6 Immunoprecipitation analysis showing that all transduced cell lines
express P- casein protein after incubation in differentiation medium for 12 days.
Analyses were repeated three times.
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Further Western analysis (Figure 4.6.1) of the relative amounts of p-casein in
the cell lines demonstrated that levels were high in NKIM2 transduced with
Tiaml-active and Tiaml-control, and TKIM2 transduced with Tiaml-active.
However as expected P-casein protein levels were low in TKIM2 transduced with
Tiaml-control. Lactating mammary gland was used as a positive control, similar
to the previous experiment. The molecular weights of the protein markers used are
indicated in kilodaltons parallel to the gel.
TKIM2 NKIM2
-act -con -act -con
Figure 4.6.1 Western analysis of P-casein expression in
transduced cell lines. Analyses were repeated three times.
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Figure 4.7 In vitro growth kinetic of transduced cell lines in standard serum and 37°C.
The points represent mean values and standard deviations from triplicate expts.
The growth curves of the four transduced cell lines were compared, similar to
previous analysis in results chapter 2. The cells were seeded at the same density
(lx 105 cells) in regular growth medium at 33°C and 37°C to control for
temperature effects. At 24 hour intervals culture plates within each series were
harvested and the cells counted. The results obtained are from triplicated
experiments, and a similar result was obtained at both growth temperatures.
Figure 4.7 illustrates that TKJM2 cells transduced with Tiaml-control had a
high growth rate. However TKIM2 cells transduced with Tiaml-active had a








In order to investigate the growth kinetics of the transduced cell lines without serum
, they were seeded at the same density (lx 105cells) at 33°C and 37°C
in normal medium for 24 hrs, then washed with serum free medium, before being
seeded in 0% serum. They were harvested and cells counted, similar to the previous
experiment. Figure 4.8 illustrates the ability ofTKIM2 cells transduced with
Tiaml-control to grow in serum-free conditions compared to the TKIM2 transduced
with Tiaml-active, and both NKIM2 cell lines transduced with Tiaml-control and Tiaml -
active. The growth ofTKIM2 cells transduced with Tiaml-control is illustrated in










Figure 4.8 Comparison of growth curves of transduced cell lines
in standard serum-free conditions (37°C).
Figure 4.8.1 Representative fields showing growth ofTKIM2 transduced with
Tiaml-control at a, 3 days and b, 6 days after seeding in serum free medium
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Soft agar formation
To assess colony formation in soft agar TKIM2 and NKIM2 were seeded into soft
agar at a series of cell densities at 37°C and 33°C. Positive control Ras-transformed
and negative control non-transformed fibroblast cell lines were supplied by D.B.
Table 4.9.1 shows that both TK1M2 cells transduced with Tiaml-control and
Tiaml-active retained the ability to form colonies in soft agar, compared with both
NKIM2 transduced lines. However the TKIM2 cells transduced with
Tiaml-active formed fewer colonies than the TKIM2 cells with Tiaml-control.
Figure 4.9.2 illustrates the growth of both TKIM2 lines in soft agar. Similar results
were obtained at both growth temperatures.
Cells seeded TKIM2 -control NKIM2-control
2xl04 12.6 +/- 1.5 0
lxlO4 11.0 +/-2.0 0
4x10J 9.2 +/-1.2 0
2x103 8.4 +/-2.0 0
lxlO3 6.4 +/-1.7 0
TKIM2 -active NKIM2-active
2xl04 3.0 +/-1.6 0
lxl 04 2.4 +/-3.0 0
4xl03 1.0 +/- 1.4 0
2xl03 1.3 +/- 1.2 0
lxlO3 1.2 +/- 1.4 0
Table 4.9.1 Comparison of Colony formation in soft agar of transduced
TKIM2 and NKIM2 at 37°C. Values are means and standard deviations.
Figure 4.9.2 Growth in soft agar of a, TKlM2-control and b, TKIM2-active, 14
days after seeding (xlO) Colonies of 5mm diameter and above were scored (37°)
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4.10 Injection into scid mice
Injection of the transduced cell lines in to scid mice resulted unexpectedly in the
formation of a single tumour in the NKIM2 transduced with control Tiaml, but not
in the other 3 cell lines (Table 4.10). The size of the tumour harvested was 10mm
and its histology which appeared to be composed of pleomorphic spindle cells
with few mitoses is illustrated in Figure 4.10.1. The mean tumour volume had not
been measured sequentially during the 4 month period.
Cell line Incidence of tumours
(Take rateO
Size of tumours after
4 months
(Diameter in mm)
NKIM2-control 1/8 (12.5%) 10 mm
NKIM2-active 0/8 (0%) —
TKIM2-control 0/8 (0%) —
TKIM2-active 0/8 (0%) —
Table 4.10 Incidence of tumour formation in scid mice, in transduced cell lines
Figure 4.10.1 Single tumour formed on injection ofNKIM2 transduced with
Tiaml-control into scid mice (x 25)
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4.11 Discussion
To date this study presents the first reversion by Tiaml of a mammary epithelial cell line
transformed by SV40 large T antigen. The only previous reversion using Tiaml, described
Hordijk et al, involved reverting Madin Derby Canine Kidney epithelial (MDCK) cells, which
were transformed by Ras [242], This discussion aims to evaluate the degree of epithelial and
mammary differentiation, and features of transformation in the reverted cells. For ease of
discussion, the features relating to epithelial and mammary differentiation in the transduced
cell lines are summarised in Table 10.
NKIM2 NKIM2 TKIM2 TKIM2
plus plus plus plus
Tiaml- Tiaml- Tiaml- Tiaml-
control active control active
Morphology epithelial epithelial spindle epithelioid
E-cadherin at all cell-cell at all cell-cell diffuse at certain
expression boundaries boundaries cell-cell
boundaries
ZO-1 expression at certain at certain no no
cell-cell cell-cell expression expression
boundaries boundaries
Junction formation adherens and adherens and no occasional
tight tight junctions adherens
junctions junctions identified junctions
Polarisation apical apical no apical no apical
microvilli microvilli microvilli microvilli
a-actin or vimentin no no no no
expression expression expression expression expression
Dome formation in dome no dome no dome no dome
differentiation formation formation formation formation
medium
p-casein expression P-casein P-casein P-casein P-casein
expression expression expression expression
Table 10 Summary of features regarding epithelial and mammary differentiation
displayed by NKIM2 and TKIM2 transduced with control and active Tiaml
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In terms of epithelial differentiation, the morphological data confirm that transduction of
TKIM2 cells with active Tiaml results in a reversion of the transformed phenotype
(Figure 5.11 a,b) to an epithelioid appearance, whereas TKIM2 cells transduced with
control Tiaml remain essentially unchanged. Although the morphological change is
striking, it is clear that certain reverted cells show membrane ruffling -a cytoskeletal
change mediated by the actin cytoskeleton [223]. Similarly, although both control and
active Tiaml do not alter the essential epithelial appearance ofNKIM2 cells, the active
Tiaml causes rounding of the cells, with some evidence of membrane ruffling
(Figure 5.1 lb). Hordijk et al. did not observe membrane ruffling after transduction of
MDCK cell lines with Tiaml [242], however previous work in fibroblasts and COS cells
has shown that the Tiaml is required for Rac-dependent membrane ruffling [233], At a
mechanistic level, membrane ruffling occurs when Rac is activated by agonists such as
platelet-derived growth factor or insulin [229]. This leads to the assembly of a meshwork
of actin filaments at the periphery of the cell to produce lamellipodia and membrane ruffles,
which may form integrin-associated complexes [229, 247], It may be that overexpression of
Tiaml stimulates these pathways leading to a degree of membrane ruffling via Rac, in the
transduced KIM2 cells [320],
The lack of classic epithelial morphology in the reverted TKIM2 cells is underlined
at an electron microscopic level where cells showed pleomorphism and irregular surfaces
(Figure 4.4.3), although to a lesser degree than the fully transformed TKIM2 cells
transduced with control Tiaml (Figure 4.4.2). Hordijk et al did not examine reverted
MDCK cells by electron microscopy [242]. Similarly previous reversion studies using E-
cadherin have not examined reverted cells using electron microscopy [212], It may be that
the appearance of the cells illustrates the conflict in the cell between the original
transforming drive and the attempts to control these by altering the morphology of the cell
at a cytoskeletal level. The reverted TK1M2 cells are very different in appearance from
NKIM2 transduced with control and active Tiaml, which retain an epithelial
morphology (Figure 4.4). These appearances tend to suggest that the reverted cells may
not function fully as normal epithelial cells.
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While the morphology of the reverted cells was not classic epithelial, the epithelial marker
E-cadherin was expressed at certain but not all, cell boundaries (Figure 4.3.1). Although
the presence of E-cadherin confirms the epithelial nature of the reverted cells, the lack of
expression at all boundaries differs from the study by Hordijk et al in which reverted cells
expressed E-cadherin at every cell-cell contact [242], It is possible that the reverted TKIM2
cells that showed membrane ruffling morphologically and thus cytoskeletal changes, were
less likely to form adherens junctions containing E-cadherin. Previous studies have shown
that E-cadherin is closely linked to the submembranous cytoskeleton; for example
transfection of E-cadherin into fibroblasts causes the redistribution of spectrin, ankyrin and
NaKATP ase to sites of cell-cell contact, similar to their arrangement in MDCK cells[302].
An alternative possibility is that formation of complex junctions containing a number of
components, is regulated by a number of signalling pathways, which may be functioning
abnormally in reverted cells-similar to transformed cells [150], As expected on electron
microscopy, the adherens junctions were less frequent in the reverted TKIM2 cells, and
appeared to be intermediate junctions rather than full desmosomes or hemidesmosomes
(Figure 4.4.4). Furthermore, ZO-1 expression was not seen in the reverted TKIM2 cells,
suggesting a lack of tight junction formation, which was confirmed on electron microscopy.
Previous work in MDCK cells has shown that E-cadherin is required for the formation of
tight junctions as well as zonula adherens and desmosomes, because removal of calcium
from the medium causes delocalisation of junctional components and subsequent treatment
with anti-E-cadherin antibodies delays junction reformation [302].
However, NKIM2 cells transduced with control and active Tiaml, express E-cadherin at
all cell-cell boundaries (Figure 4.3) as well as showing an epithelial morphology. This is
consistent with the study carried by Hordijk et al, in which overexpression ofTiaml in
normal MDCK epithelial cells increased E-cadherin-mediated cell adhesion. This was
demonstrated by increased resistance of transduced cells to scattering induced by
Hepatocyte Growth Factor [242]. In order to explain the increased cell adhesion, Hordijk
et al proposed that localization of Tiam 1 at adherens junctions may lead to Rac-mediated
F-actin polymerisation, which may facilitate the association of E-cadherin complexes
with the cortical actin cytoskeleton.
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If, as Hordijk et al suggest, upregulating Tiaml results in association of E-cadherin
complexes with the actin cytoskeleton, one might predict a difference in the junction-
associated proteins P- and a- catenin. However, these were not altered in their study [242],
a- and P-catenin were not individually assessed in this study, although the whole
junctional formation was examined by electron microscopy.
The possibility that part of the regulation of E-cadherin by Tiaml may be transcriptional
is raised by the Western analysis showing an upregulation of Tiaml in lines transduced
with the active Tiaml construct compared with the control, although this is more convincing
in NKIM2 cells compared with TKIM2 cells (Figure 4.3.2) Supporting this evidence are
previous studies examining carcinoma cell lines in vitro which have found that the relative
amounts of E-cadherin protein and mRNA correspond to each other in E-cadherin expressing
lines [212], Moreover an E-cadherin promoter has been characterised, which is bound by
certain transcription factors and is known to control epithelial-specific gene expression [261].
Further exploration of this transcriptional regulation is required, and will be considered in the
general discussion.
It is clear from electron microscopy that polarisation was absent in reverted TKIM2
cells , although present in NKIM2 cells transduced with control and active Tiam
(Figure 4.4). The lack of polarisation in reverted cells could be predicted from the
junctional abnormalities and relative lack of E-cadherin already discussed. Although
previous studies have shown that MDCK cells in collagen maintain their apical orientation
even when their basolateral orientation is disrupted by loss of E-caderin contacts through
calcium depletion [302],
In contrast with the lines before genetic manipulation, none of the transduced cell lines
appeared to contain other cell types, in terms of a-actin-expressing myoepithelial cells, or
vimentin-expressing fibroblasts. This was confirmed by electron microscopy, where neither
cell type was identified. The original untransduced NKIM2 and TKIM2 cell lines did not
contain fibroblasts (section 2), so it is reasonable to expect that the transduced cells similarly
do not contain this cell type. However small numbers of myoepithelial were present in
untransduced NK1M2 (Figure 1.2 ), and the retroviral transduction of cells occurred with
high efficiency, so one would predict the presence ofmyoepithelial cells among transduced
NKIM2 lines
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It is possible that by chance alone the myoepithelial NKIM2 cells were not transduced, or it
may be that the myoepithelial cells did not survive following retroviral transduction. In
principle the retrovirus should have transduced both cell types with the same efficiency
because its cell surface receptors were specific for all murine cells types [205].
Formal experiments comparing epithelial and myoepithelial cells are necessary to determine
whether there is a real difference in transduction of these cell types, however the numbers of
myoepithelial cells among NKIM2 cultures are too small to make meaningful comparisons.
While the lack ofmyoepithelial cells in transduced cultures remains difficult to explain, it is
convenient, because all transduced cell lines can be considered epithelial cultures.
In terms of mammary differentiation, the reverted TKIM2 cells express milk protein in
response to lactogenic hormones. From the data all transduced cell lines show the ability to
form p-casein on immunoprecipitation analysis (Figure 4.6.) where the bands only reveal
that P-casein is present. This analysis involves specific probing and detection steps which
produce a specific clean result, when using a polyclonal or less specific antibody. Further
investigation of the relative amounts of p-casein in each cell line by Western analysis,
revealed that the reverted TKIM2 lines produce P-casein in similar amounts to other
NKIM2 lines (Figure 4.6.1). TKIM2 transduced with control Tiaml express very small
amounts of P-casein compared to other lines, and less than untransduced TKIM2 cells
(Figure 1.9). To date the main players in mammary differentiation and lactogenesis appear
to be prolactin and the JAK-STAT pathway [327], Recent evidence has shown cross-talk
between the JAK-STAT pathways and the Ras-mediated signalling. It is possible that Tiam 1
stimulation of Rac-which is known to effect Ras pathways, may provide a link to pathways
that control milk gene expression. Alternatively, it may be the partial restoration of epithelial
differentiation which is key to promoting high levels of milk protein expression.
Reverted TKIM2 cells were unable to form dome-like structures after growth in lactogenic
hormones. As discussed in results (section 1) the significance of these structures to mammary
differentiation requires further exploration. However it is more likely that cells were not able
to form domes as a result of junctional aberrations, than any lack ofmammary differentiation.
This may also be responsible for the inability ofNKIM2 cells transduced with active Tiaml
to form domes, compared with NKIM2 cells transduced with control Tiaml (Figure 4.1.2).
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In order to help consider whether the features of transformation are suppressed in reverted
cells, Table 10.1 displays features of transformation in all the transduced cell lines
NKIM2 NKIM2 TKIM2 TKIM2
plus plus plus plus
Tiaml- Tiaml- Tiaml- Tiaml-
control active control active
Contact contact contact no contact contact
Inhibition inhibition inhibition inhibition inhibition
Serum serum serum serum serum
independence dependent dependent independent dependent
Growth in soft no colonies no colonies colonies colonies
agar
Injection of 1 out of 8 no tumour no tumour no tumour
scid mice tumour formation formation formation
Table 10.1 Features of transformation in transduced cell lines
The morphological data confirms that reverted TKIM2 cells transduced with active Tiaml
regained contact inhibition and grew in a flat monolayer (Figure 4.1.1). This induction of
contact inhibition in reverted cells was also observed in the previous Tiaml reversion study
by Hordijk et al [242]. As expected, both NKIM2 cell lines retained the feature of contact
inhibition, similar to untransduced NKIM2 cell lines (Figure 4.1 a,b).
It is clear the rate of growth of reverted TKIM2 cells was reduced, with a similar growth
rate to the two NKIM2 cell lines (Figure 4.7). The lack of growth in reverted cells
would tend to suggest that Tiaml is influencing another feature of transformation -namely
uncontrolled growth. This is further confirmed by the inability of reverted cells to grow
serum-free conditions (Figure 4.71), suggesting the cells have become dependent on growth
factors in the serum for proliferation.
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While contact inhibition and growth control appear to be reinstated in reverted TKIM2 cells,
unexpectedly the reverted TKIM2 cells transduced with active Tiaml showed anchorage-
independent growth in soft agar. Fewer colonies were formed in reverted TKIM2
cells compared TK1M2 cells transduced with control Tiaml (Figure 4.9.1).While there is
considerable data on how transformed cells usurp growth control, studies on the mechanisms
that govern cellular location and anchorage-dependence have lagged considerably. Evidence
demonstrating that integrins transduce signals that influence intracellular pathways have
provided some insight into anchorage independence [ 177].The disparity between induction of
growth control and anchorage-dependence is interesting in the Tiaml - reverted cells, because it
is known that there is conversion of integrin and growth factor pathways at certain points and
that certain oncogenes can stimulate each pathway separately before conversion. Therefore it
may be that Tiaml may be reverting pathways controlled by growth factor receptors and not
integrins. Although it is likely that there is some cross talk between pathways, particularly
because the colony- formation is reduced in reverted TK1M2 cells compared with TK1M2
cells transduced with control Tiaml.
While reverted TKIM2 cells did not form tumours in scid mice, the most unexpected result
was the formation of a single tumour in scid mice in normal NK1M2 cells transduced with
control Tiaml, but in no other population (Figure 4.9). It has been shown that normal
untransduced NKIM2 cells could form tumours in scid mice (Figure 2.7), so it is feasible
that NKJM2 cells transduced with the control construct could do likewise. However the
lack of tumour formation in TK1M2 cells transduced with the control Tiaml construct is
surprising. One explanation for the low tumour take rates overall, is that both control and
active Tiaml are in general are reducing the tumour forming ability of all the cells, although
the mechanism of action of the control construct would not be clear. An alternative explanation
is that the process of retroviral transduction may have reduced the tumour forming ability
of the cells in general. The only way to confirm whether the retroviral transduction is having
this effect would be to transduce cells with an empty vector and compare their tumourigenicity
in scid mice. However considering the previous low take rates in scid experiments, it is more
likely that this experiment has not been optimised for these cell lines as discussed in Results
chapter 2.
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So, in conclusion to what extent do transformed cells which have been reverted by Tiaml,
show epithelial and mammary differentiation, and to what degree have the features of
transformation been reversed in these cells? The reverted cells do show a remarkable
reversion to an epithelioid phenotype with restoration of the key features of epithelial
differentiation-namely E-cadherin expression at certain cell boundaries and adherens
junctions. However further examination shows that the cells are unable to fulfil more
complex criteria such as polarisation, tight junction formation and they still show
considerable morphological irregularities under electron microscopy. They are capable of
expressing the milk protein P-casein and so demonstrate mammary differentiation.
In general, the reverted cells have lost their features of transformation including lack of
contact inhibition, rapid growth rate and lack of serum-dependence. However they
retained the ability to form anchorage-independent colonies in soft agar. Although reverted
cells did not form tumours in scid mice, the results from this experiment are difficult to
interpret because the only cell line which did form a tumour was NKIM2 cells transduced
with the control Tiaml construct.
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General Discussion
To date this is the first description of Tiaml- reversion ofmammary cells
transformed by SV40 large T antigen, and a consideration of how this extends
current knowledge is necessary.
Cells previously reverted by Tiaml were transformed by an oncogenic mechanism-
namely a Ras-transformed pathway [242], In Ras- transformation, a point mutation
in a Ras gene can create a Ras protein that fails to hydrolyse its bound GTP and so
persists abnormally in its active state, transmitting an intracellular signal for cell
proliferation. Whereas the strategy of SV40 large T antigen involves binding to the
protein products of two key tumour suppressor genes of the host cell, putting them
out of action and so permitting the cell to replicate its DNA and divide [120],
Although both mechanisms result in unregulated cell proliferation, it is unlikely that
overexpression ofTiaml would result in the specific reversion of these two different
mechanisms of for transformation.lt appears more likely that by promoting a physical
morphological change- by rearranging F-actin and promoting E-cadherin contacts
between cells, Tiaml can atleast partially overcome transformation by Ras and SV40
large T antigen. This theory would be strengthened by exploring the reversion
capability in cells transformed by an alternate mechanism. Initial data suggests that
Tiaml may be also able to revert src-transformed cells (J.C. personal communication).
Although as a concept the suppressive effect on transformation appears surprising, it may
be that cell-cell contact stimulates a number of signalling pathways which are as yet
unknown. Certainly it is clear that restoration of E-cadherin and a functional cadherin/
catenin complex in various cell culture systems transformed by different mechanisms,
can revert lines to a benign epithelial phenotype [243]. At a cell signalling level, it has
been proposed that E-cadherin sequesters (3-catenin in the E-cadherin cell-adhesion
complex, and thus prevents free P-catenin from stimulating the Wnt signalling pathway
which may promote uncontrolled cell proliferation in the context of tumourigenesis
[257]. However while data supports a connection between E-cadherin function and p-
catenin transcriptional activity in vitro, it remains uncertain whether this link is
physiologically relevant.
143
This study raises the possibility that Tiaml may regulate E-cadherin through a
transcriptional mechanism, by demonstrating upregulation of the E-cadherin protein
expression by active Tiaml. However to date knowledge of the E-cadherin promoter
and possible transcriptional regulators is limited. Analysis of the E-cadherin promoter in
mice has shown epithelial specificity 178 base pairs upstream of the transcription start
site [270], This promoter fragment contains a GC-rich region, a CCAAT -box and a 12
base pair palindromic element named E-Pal [261], and these components are also present
in human E-cadherin. It is thought that epithelium specific regulation of E-cadherin may
be controlled by two mechanisms. Firstly, the E-Pal element acts as a promoter or
repressor of gene expression depending on whether or not it is in epithelial or
mesenchymal cells respectively. Secondly a tissue specific enhancer (ESE) promotes
transcription exclusively in epithelial cells [261], It has been reported that both these
mechanisms have been disturbed in MCF-7 breast carcinoma cell lines [271].
In terms of trancriptional regulation, E-Pal has consensus sequences for binding of helix-
loop-helix (HLH) transcription factors, which are implicated tissue-specific gene
expression, although functional activity has not yet been demonstrated. The CCAAT- box
family of proteins CP-1 and C/EBP also have binding activity for the CCAAT box ofE-
cadherin, and the ESE element enhances transcription through AP2 [261 ]. However none
of these transcription factors have been associated with Tiaml to date.
It may be that a prime candidate for transcriptional regulation of E-cadherin
via Tiaml has not been appreciated to date in the reversion context. Recent work has
shown that the Tiaml family of guanine nucleotide exchange factors (Dbl, Ost and Vav),
via the activation of the members of the Rho family of GTPases stimulate the
transcription factor Nuclear Factor -kappa B (NF-kB ) [251 ]. Although NF-kB is
traditionally associated with the response to pathogens or stress, it can modulate
expression of the cell adhesion molecules P, E-selectin, ELAM-1, ICAM, VCAM-1,
integrins al P2, and vimentin [253], Therefore NF-kB is a potential candidate for a
transcriptional regulator of E-cadherin and phenotypic reversion, although a DNA
binding site for NF-kB has not been previously described on the E-cadherin promoter.
Moreover unlike Tiaml, abnormal NF-kB activity has been implicated in human breast
carcinogenesis and therefore may be physiologically relevant.
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It has been reported that highly expressed pl00/p52 precursor NF-kB sequesters other
NF-kB proteins in cytoplasm of human breast cancer cell lines, thus abrogating its
normal function in cancer cells [277]. Other studies have reported abberant activation of
NF-kB in human breast tumour lines, rat and human breast cancer specimens, although
detailed analysis of sub-units is not demonstrated [278]. However, alternative data, also
in tumour lines, suggests that constitutive activation ofNF-kB occurs during the
progression of certain human breast cancers from being antioestrogen-sensitive (ER
positive) to insensitive (ER negative) [279], The role ofNF-kB in the Tiaml reversion
pathway therefore requires further exploration, and an initial approach would involve
confirming by Electrophoretic Mobility Shift analysis (EMSA) whether active Tiaml
upregulated the NF-kB transcription factor in transduced KIM2 lines.
It is highly likely that Tiaml is stimulating alternative pathways in the KIM2
system, which also require exploration. For example, in certain cell types, Tiaml via Rac
can stimulate c-jun N-terminal kinase [233] and moreover, activated Racl has also been
shown to activate the p38/Mpk2 pathway which is induced by different stress conditions
[321], as well as regulate the transcriptional activity of serum response factor (SRF)
[322],
An alternative approach to considering the individual cell signalling pathways affected
by reversion, is to consider the key changes triggered by overexpression of Tiaml and the
implications of these. Figure 1 depicts a scheme for considering the effects of Tiaml on
transformation and differentiation from this study.
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From Figure 1 it is clear that in terms of features of transformation that reorganisation
and restoration of cell-cell contacts by Tiaml affects morphology- and could explain
a reorganisation from a spindle to a cuboidal phenotype. Similarly induction of
contact inhibition may result also from generalised increased cell-cell adhesion.
However it has been shown in vitro that contact inhibition is also facilitated in normal
cells by increased cell-substratum adhesion at the periphery of the cell, which prevents
migrating cells underlapping normal cells [175], Cell-substratum interactions are
normally mediated by certain integrins, and presumably help prevent invasion in
vivo.
While Tiaml controls serum-independent growth mediated by growth factor pathways
in reverted cells, anchorage-independence mediated by integrin pathways remains
present. Several studies have shown that the ability of cancer cells to proliferate in the
absence of adhesion to extracellular matrix proteins ie anchorage-independence,
correlates closely with tumourigenicity in animal models [181], This property of cancer
cells presumably reflects the tendency of tumour cells to survive and grow in
inappropriate locations in vivo. Although tumourigenicity was explored in reverted
eel Is-which did not form tumours, this question remains unanswered because certain
control lines were tumourigenic. Furthermore perhaps the most significant question
was not answeredby this study , namely can Tiaml prevent cells from metastasizing.
The key difference between tumourigenicity and metastasis, is the ability for detached
cells to destroy the extracellular matrix by proteolysis and invade. Importantly the first
stage ofmetastasis involves decreased E-cadherin adhesion, in order to allow cells to
detach [32], Therefore it may be more significant in vivo that Tiaml prevents cell-
detachment from an existing tumour rather than full reversion of the transformed
phenotype. To explore this further, it would be more profitable to overexpress Tiaml
in a human breast cancer line which is known to cause metastasis, rather than in
KIM2 mammary cells which may be less likely to metastasize.
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Assessment of epithelial and mammary differentiation allows a prediction of how close
reverted cells are to 'normal', and the effect of overexpression of Tiaml on normal cells.
From Figure 1, it is clear that Tiaml promotes E-cadherin expression between cells, one
of the hall marks of epithelia, however in this study expression was not universal,
possibly due to the effect of Tiaml on other signalling pathways such as those controlling
membrane ruffling. It is probable that lack of E-cadherin or conflict between signalling
pathways inhibited tight junction formation and polarisation in reverted cells.
However reverted cells exhibit mammary differentiation in terms of milk expression,
which is controlled by prolactin via JAK-STAT pathways [327], This contrasts with
previous studies which show that mammary differentiation is dependent on epithelial
differentiation [84], Moreover the only similar study reversing the effects of
immortalization in mammary HC11 cells, showed that reintroducing and overexpressing
wild-type p53 inhibited the expression of atleast two milk proteins [89], However the
HC11 cells with wild- type p53 also exhibited generalised growth inhibition which may
have contributed to the lack of milk protein expression.
Clearly it is possible to revert transformed cells in the in vitro scenario, but how does this
translate to in vivo clinical objectives in the management of breast cancer ?. Perhaps the
results are most relevant to the field of gene therapy. To date the most successful
approach using gene therapy combined with enzyme therapy, has been the treatment of
Adenosine Deaminase Deficiency- a genetic disease that leaves patients prone to
infection [207], Although many strategies are currently employed with regards to cancer
gene therapy, success has been limited. They include reinjecting genetically modified
lymphocytes to destroy tumours, enhancing the immune reaction to genetically modified
tumour cells, corrective approaches eg restoring wild-type p53, and triggering apoptosis
pathways [207], The main problems have been related to low gene transduction of the
target tissue and vector-related problems [202],
Technical problems aside, it is intriguing to speculate that stimulation of the Tiaml
pathway could be used in gene therapy treatment, to revert transformed cells.
However the data from this study clearly demonstrate that both normal and transformed
Tiaml transduced cells, show certain abnormal biological features. In vivo, Tiaml
appears tightly regulated and its precise role in vivo is still to be elucidated.
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Therefore there may be significant hazards involved in overexpressing Tiaml in normal
tissue in vivo. In contrast, the targetting of cancer cells only, with Tiaml may be a
feasable longterm objective, particularly if gene therapy becomes a clinical option. It is
unlikely that Tiaml would revert tumours to normally functioning tissue, but it may be
that a degree of growth control is restored, and perhaps tumourigenicity would abolished.
Perhaps the most crucial question will be whether or not overexpressing Tiaml
suppresses the ability of cells to metastasize.
An alternative possibility is that other components of the reversion pathway are used
in gene therapy which disrupt fewer signalling pathways in general. For example it may
be that direct restoration ofwild-type of E-cadherin in cancers where it is mutated or
deleted proves to be as effective, as indicated by early mouse experiments [267].
These elegant experiments using a transgenic mouse model for pancreatic Beta cell
carcinogenesis showed that crossing these mice with those that maintain E-cadherin
expression, halted the process of tumourigenesis at the adenoma stage [267].
It may be that apart from examining cell signalling pathways in vitro, the next step
in the research of Tiaml would involve using transgenic animals to help determine the
function ofTiaml in vivo and ultimately its effect on tumourigenesis.
It could be argued that the Tiaml reversion in murine KIM2 cells are more representative
of in vivo human disease than previously reverted canine kidney epithelial cells [242],
However although the KIM2 model does inactivate p53 and pRb, which have been
implicated in human breast carcinogenesis, this is only indirectly through SV40
large T antigen.
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In conclusion how far were the aims of this study achieved?
The KIM2 mammary model clearly provides a model for normal and transformed cells,
which is amenable to genetic manipulation with Tiaml. Although several other
experimental normal breast and breast cancer cell lines exist, the advantage of this system
is that both lines derived from a common origin. Therefore one could predict that the
differences between the cell lines are a consequence of transformation only, rather than
any intrinsic difference between the cell lines. However as discussed one potential
drawback of the system is a degree of chromosomal variability shown in both normal and
transformed cells, although this is present in many in vitro cell lines [73]. This variability
may have been responsible for the formation of tumours in scid mice by NKIM2 cells
The retroviral transduction ofNKIM2 and TKIM2 cells proved a successful method of
gene transfer in these cells. Previous attempts to transfect these cells by conventional
techniques have proved very inefficient [318]. Furthermore, it is clear that overexpression
of the transgene occurred for atleast three months following transduction, despite
presumed changes in the chromosomal content of the cells.
It is clear that Tiaml can atleast partially revert SV40 large T antigen transformed
mammary TKIM2 cells to an epithelial phenotype. This is significant because it
suggests that Tiaml is effective in reverting different mechanisms
of transformation, because previous reverted cells were Ras-transformed [242].
Furthermore, the reversion also provides a model for future examination of the
components of the Tiaml signalling pathway, in particular the transcription factor
NF-kB, which may be involved in the transcriptional regulation of E-cadherin.
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